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ABSTRACT 
 
Peter Mahan Douglas: The dynamic role of Hsp40 chaperones in  
protein aggregation and proteotoxicity 
(Under the direction of Douglas Cyr) 
 
Protein homeostasis or proteostasis involves an intricate balance between the 
synthesis, folding, localization and degradation of each protein in the cell.  Perturbations 
by age or chronic stress can compromise any one component of this integrated network 
and initiate a cascade of toxic misfolding events. Protein conformational disorders such 
as Alzheimer’s disease, transmissible spongiform encephalopathies, and the 
polyglutamine-expansion diseases are characterized by the misfolding and subsequent 
conversion of disease-related proteins into β-sheet-rich conformers capable of assembling 
into highly ordered aggregates termed amyloid. For over a century, amyloid fibrils were 
believed to represent the toxic agent behind these diseases due to their overwhelming 
presence in postmortem brains of diseased individuals. However, recent evidence has 
begun to challenge the notion that amyloid formation is the toxic mechanism.  Two 
observations described herein suggest that amyloid formation provides the cell a 
mechanism to buffer the formation of toxic protein species. First, my studies demonstrate 
that amyloid formation by the yeast prion protein, Rnq1, protects cells against 
proteotoxicity. Interestingly, the Hsp40 chaperone, Sis1, mediates the efficient 
conversion of nascent Rnq1 into amyloid-like, [RNQ+] prion assemblies.  Inefficiencies 
in Sis1-mediated [RNQ+] assembly result in the toxic accumulation of soluble, low 
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molecular weight oligomers. Second, Sis1 activity relocates [RNQ+] prion assembly 
pathways from the cytosol to the nucleus, in which [RNQ+] assembly was more efficient 
and less toxic. Sis1 modulates the conformation of [RNQ+] prions which, in turn, act as 
environmental factors to promote toxicity of a huntingtin’s protein exon-1 fragment with 
an expanded polyglutamine tract (Htt-103Q). Complex formation between [RNQ+] prions 
and Htt-103Q enabled nuclear [RNQ+] aggregates to attract Htt-103Q from the cytosol to 
the nucleus, which reduced the efficiency of nuclear Htt-103Q aggregation and 
exacerbated Htt-103Q toxicity. Thus, amyloid formation appears to represent a protective 
mechanism to ameliorate the toxic accumulation of small, soluble intermediates in the 
aggregation pathway. My studies also demonstrate that molecular chaperones directly 
and indirectly influence the cellular location of amyloidogenic proteins and therefore 
have a profoundly impact on proteotoxicity because the cytosol and nucleus have 
different capacities to package disease proteins into benign assemblies.  
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Molecular Chaperones antagonize proteotoxicity by differentially modulating 
protein aggregation pathways 
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1.1 Abstract 
The self-association of misfolded or damaged proteins into ordered amyloid-like 
aggregates characterizes numerous neurodegenerative disorders. Insoluble amyloid 
plaques are diagnostic of many disease states. Yet soluble, oligomeric intermediates in 
the aggregation pathway appear to represent the toxic culprit. Molecular chaperones 
regulate the fate of misfolded proteins and thereby influence their aggregation state. 
Chaperones conventionally antagonize aggregation of misfolded, disease proteins and 
assist in refolding or degradation pathways. Recent work suggests that chaperones may 
also suppress neurotoxicity by converting toxic, soluble oligomers into benign 
aggregates. Chaperones can therefore suppress or promote aggregation of disease 
proteins to ameliorate the proteotoxic accumulation of soluble, assembly intermediates. 
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1.2 Introduction 
Many neurodegenerative disorders are characterized by the misfolding and 
subsequent aggregation of toxic proteins. Alzheimer’s, Parkinson’s, and the glutamine-
encoding expansion diseases are examples of conformational disorders which show late 
onset symptoms of progressive neuronal dysfunction and eventual neuronal loss within 
certain brain regions (Carrell and Lomas, 1997). The disease-causing protein can adopt 
aberrant conformations due to age or stress which enables its aggregation and ultimate 
accumulation in amyloid fibrils (Figure 1.1) (Balch et al., 2008; Morimoto, 2008). 
Amyloids share a β-sheet-rich, fibrillar protein conformation in which the β-sheets stack 
parallel or anti-parallel to one another and run perpendicular to the fiber axis (Caughey 
and Lansbury, 2003; Nelson et al., 2005). Numerous pathogenic substrates as well as 
yeast prion proteins can exist in alternate, amyloid-like states that are characterized by a 
defined set of biochemical parameters including the ability to bind indicator dyes such as 
Thioflavin or Congo Red as well as resistance to both protease digestion and detergent 
solubilization (Chiti and Dobson, 2006). Though the appearance of amyloid is diagnostic 
of the disease state, the extent of amyloid accumulation often does not correlate with the 
disease symptoms (Caughey and Lansbury, 2003; Haass and Selkoe, 2007).  In fact, a 
wide variety of organisms utilize functional forms of amyloid-like structures to perform 
important cellular processes such as phenotypic adaptation in yeast (Shorter and 
Lindquist, 2005; True et al., 2004; Uptain and Lindquist, 2002) and melanin synthesis in 
humans (Fowler et al., 2006). These and other lines of evidence suggest that amyloid 
formation per se is not toxic but may represent a benign by-product or even a protective 
mechanism (Arrasate et al., 2004; Cheng et al., 2007; Douglas et al., 2008).   
  
 
 
Figur
protei
misfo
deterg
cell d
interm
aggre
misfo
 
 
e 1.1 Schem
n can adopt 
lded, disease
ent-soluble o
eath. In thi
ediates. Alte
gates. The fo
lded protein m
atic represe
a non-native
 protein can 
ligomers an
s model, w
rnatively, th
rmation of a
onomers int
ntation of t
 conformatio
then self-ass
d/or protofib
e speculate 
e misfolded 
myloid seed
o β-sheet-ric
 
4 
he amyloid 
n due to int
ociate into d
rils whose in
about the s
protein can 
s drives the 
h, amyloid ag
assembly pa
rinsic and/or
ifferent inter
tracellular a
tructural pro
accumulate a
autocatalytic
gregates. 
thway. A d
 environmen
mediate stru
ccumulation 
perties of t
s non-specif
 conversion 
isease causin
tal stress. Th
ctures such a
correlate wit
he ill-define
ic, amorphou
of native an
g 
e 
s 
h 
d 
s 
d 
5 
 
Soluble intermediates in the amyloid assembly pathway appear to represent the 
toxic species (Haass and Selkoe, 2007; Kayed et al., 2003). Relatively little is known 
about the exact nature of the assembly intermediates due to their dynamic structure 
(Figure 1.1). Antibodies generated against the Aβ42-peptide (proteolytically cleaved 
peptide from the Amyloid Precursor Protein, APP, and a causative agent for Alzheimers 
disease) could recognize assembly intermediates formed by numerous amyloidogenic 
substrates and buffer their cytotoxicity (Kayed et al., 2003). Subsequent work 
demonstrated that the same conformational-specific antibodies could selectively inhibit 
spontaneous amyloid formation of yeast prions in vitro (Shorter and Lindquist, 2004; 
Vitrenko et al., 2007). Thus, amyloid assembly intermediates, which include soluble 
oligomers, do exhibit common conformation-dependent structures that are unique to the 
intermediates regardless of the amino acid sequence.     
The accumulation of oligomeric amyloid assembly intermediates closely correlates 
with cell death (Haass and Selkoe, 2007), and distinct clearance pathways maintain the 
proteotoxic oligomers at low levels (Cohen et al., 2006). This can be accomplished by 
either solubilizing the aggregation-prone substrate or driving its assembly into higher-
ordered amyloid-like aggregates. The ability to promote aggregation does not necessarily 
represent the cell’s primary means of clearance but may provide backup pathways when 
solublization machinery has become compromised by age or environmental insult (Cohen 
et al., 2006). The nature and identity of the unfavorable interactions between the soluble 
oligomers and other cellular components is just being defined and may result in 
transcriptional deregulation (Burke et al., 1996; Dunah et al., 2002; Steffan et al., 2000), 
proteasomal inactivation (Bence et al., 2001), aberrant signaling (Small et al., 2001), or 
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membrane damage (Arispe et al., 1993; Kremer et al., 2001; Volles et al., 2001). It should 
be noted that disease proteins associated with conformational disorders perform a wide 
variety of cellular functions and scenarios may exist where protein species other than 
amyloid assembly intermediates represent the predominant toxic species. 
All cells contain quality control machinery termed molecular chaperones to 
maintain the appropriate folding state of proteins. Many of these molecular chaperones 
have been termed Heat-Shock Proteins (HSP) due to their increased expression upon heat 
treatment of cell and have been divided into six major families including HSP100, 
HSP90, HSP70, HSP60, HSP40, and the small HSPs (Muchowski and Wacker, 2005). 
Chaperones recognize misfolded protein conformers and ultimately coordinate the 
appropriate folding or degradation pathways. As the first line of defense against 
conformational disorders, chaperones maintain the solubility of misfolded, disease-
related substrates by directly binding to non-native conformers or disassembling 
aggregates formed by the disease protein (Muchowski and Wacker, 2005). Alternatively, 
recent evidence suggests that chaperones can also promote aggregation and thereby 
prevent the toxic accumulation of amyloid assembly intermediates (Behrends et al., 2006; 
Douglas et al., 2008). Herein we discuss how molecular chaperones manage proteotoxic 
misfolding events of numerous amyloidogenic substrates.  
 
1.3 Molecular chaperones antagonize aggregation of disease proteins 
Chaperones act by multiple means to maintain the solubility of disease-causing 
proteins. Chaperone-mediated solubilization can occur in the initial stages of the amyloid 
assembly pathway by preventing the self-association of misfolded, disease proteins into 
toxic, oligomeric intermediates. Alternatively, chaperones also act later in the assembly 
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pathway to dismantle amyloid-like aggregates and resolubilize the disease protein. Thus 
chaperone intervention can either maintain or generate disease protein monomers which 
can be properly refolded or marked for degradation by the ubiquitin-proteasome system 
or autophagy pathways. This reduces the flux of misfolded, disease proteins through 
different stages of the amyloid assembly pathway and decreases the cellular 
concentration of proteotoxic assembly intermediates. 
 
1.3.1 Chaperones prevent disease proteins from assembling into amyloid-like 
aggregations 
Chaperone machinery can act early in the amyloid assembly pathway by 
recognizing misfolded, disease proteins and subsequently preventing their aggregation. 
The Hsp70 chaperone system has been well-defined in its role of preventing the assembly 
of different, disease-causing proteins into amyloid-like aggregates (Bonini, 2002; 
Muchowski and Wacker, 2005). The Hsp70 family of chaperone proteins is abundantly 
expressed throughout the cell and contains 11 known isoforms in humans (Tavaria et al., 
1996). Though not as abundant as its Hsp70 partner, the Hsp40 co-chaperone (also 
referred to as J-proteins due to their highly conserved J-domain) represent a more diverse 
family of proteins which contain 41 isoforms in humans and are present in most every 
intracellular compartment (Qiu et al., 2006). The structural and functional diversity of 
Hsp40 co-chaperones provide specific substrate recognition properties for the Hsp70 
work horse (Fan et al., 2003).   
The misfolding of disease proteins can arise from numerous intrinsic or 
environmental stresses (Balch et al., 2008), and Hsp70 cooperates with different Hsp40 
co-chaperones to ultimately recognize and refold the non-native protein conformers 
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(Figure 1.2). Hsp40 can bind hydrophobic peptides which are normally buried in the core 
of natively folded proteins but become solvent-exposed in misfolded states (Rudiger et 
al., 2001). The polypeptide binding domain of Hsp40 binds non-native proteins and 
delivers them to Hsp70 (Cheetham and Caplan, 1998; Cyr and Douglas, 1994). The 
ability of Hsp70 to bind the misfolded substrate is tightly regulated through an ATP 
hydrolytic cycle. Once in a complex with Hsp70, the J-domain of Hsp40 stimulates ATP 
hydrolysis on Hsp70 which promotes a conformational change in the Hsp70 substrate-
binding domain and increases its binding affinity for the misfolded substrate (Cyr et al., 
1992; Langer et al., 1992; Liberek et al., 1991). Hsp40 is liberated from the 
Hsp70:substrate complex following ATP hydrolysis yet it is unclear how co-chaperone 
release occurs. The substrate in complex with Hsp70 can be properly refolded, marked 
for degradation via Hsp70 coordination with degradation machinery, or released to re-
enter this binding cycle. The substrate remains tightly bound to Hsp70 until ADP is 
exchanged for ATP via a diverse class of nucleotide exchange factors (NEF) (Bukau et 
al., 2006). It is in this manner that cooperation between Hsp40 and Hsp70 prevents the 
proteotoxic accumulation of misfolded, aggregation-prone proteins.  
The involvement of nucleotide exchange factors (NEF) adds yet another level of 
regulation to the Hsp70 system. This diverse family of exchange factors is critical for the 
functional cycle of Hsp70 because they replace ADP for ATP on Hsp70 and trigger 
substrate release (Bukau et al., 2006). Well characterized NEFs include the bacterial 
GrpE, which facilitates nucleotide dissociation from the Hsp70 (DnaK) (Liberek et al., 
1991; Zylicz et al., 1987), and the BAG family of eukaryotic proteins which are NEFs for 
different cytosolic Hsp70s (Bimston et al., 1998). A third family of proteins which  
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possess nucleotide exchange activity including the cytosolic Fes1 and ER luminal Sls1 in 
Saccharomyces cerevisiae (Kabani et al., 2002; Kabani et al., 2000), and the human 
ortholog HspBP1 (Hsp70 binding protein 1) (Raynes and Guerriero, 1998). Interestingly, 
other molecular chaperones are capable of nucleotide exchange on Hsp70. The yeast 
Hsp110, Sse1, regulates nucleotide exchange on different cytosolic Hsp70s (Raviol et al., 
2006), while the Hsp170, Lhs1, stimulates nucleotide exchange of the ER Hsp70, Kar2 
(Steel et al., 2004). Sse1 is a particularly interesting exchange factor because its activity 
in yeast is required for the propagation of the [URE3] prion (Kryndushkin and Wickner, 
2007), as well as the formation and propagation of the [PSI+] prion (Sadlish et al., 2008). 
The recent findings which implicate Sse1 in the formation and propagation of amyloid-
like prions may establish a better understanding of how nucleotide exchange on Hsp70 
affects amyloid dynamics. Thus, the cell can utilize this diverse family of NEFs to 
regulate the different activities of Hsp70 in distinct subcellular compartments. 
The ability of Hsp70 and Hsp40 to suppress the assembly of disease proteins into 
amyloid-like aggregates has been well documented in numerous model systems 
(Muchowski and Wacker, 2005), yet only a few examples will be discussed. Glutamine-
encoding repeats within a set of unrelated proteins are the cause of at least nine different 
late onset neurodegenerative disorders (Ross, 2002; Zoghbi and Orr, 2000). Elevating 
intracellular pools of Hsp70 as well as Hsp40 reduce expanded-polyQ aggregate 
formation and suppressed toxicity in cultured cells (Chai et al., 1999; Jana et al., 2000; 
Kobayashi and Sobue, 2001). Due to the high conservation of chaperone machinery 
between eukaryotic cells, Saccharomyces cerevisiae has emerged as a model system to 
study protein aggregation and toxicity. Overexpression of the yeast Hsp70, Ssa1, or the 
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Hsp40, Ydj1, inhibit the formation of large, detergent-insoluble aggregates by an 
expanded-polyQ protein containing the N-terminal sequence of the huntingtin protein, the 
causative gene for Huntington’s disease (Muchowski et al., 2000). Ydj1 also reduced the 
aggregation of the Q/N-rich prion domain of the yeast prion, Rnq1, which correlated with 
its ability to suppress prion toxicity (Summers et al., 2008). Elevated expression of 
another yeast Hsp40, Sis1, reduced the aggregation of expanded-polyQ Htt protein and 
suppressed toxicity in [psi-] yeast, which are void of the amyloid-like [PSI+] prion 
(Gokhale et al., 2005). Hsp70 and Hsp40 have also been shown to suppress the 
aggregation and toxicity of numerous other disease-causing proteins including mutant 
superoxide dismutase 1 (SOD) (Takeuchi et al., 2002), a causative gene for familial 
amyotrophic lateral sclerosis, and α–synuclein (Klucken et al., 2004), a causative gene 
for Parkinson disease. Thus, the ability of Hsp70 and Hsp40 to prevent assembly of 
amyloid-like aggregates and suppress cytotoxicity extends to numerous disease-causing 
proteins in a variety of model organisms. 
  
1.3.2 Molecular chaperones solubilize protein aggregates 
Chaperones can act later in the aggregation pathway to disassemble amyloid-like 
particles. Although it is unclear whether mammalian cells possess this disaggregation 
activity, fungi, plants and bacteria express the AAA ATPase protein remodeling factor, 
Hsp104 (ClpB in E. coli) (Shorter, 2008). The hexameric Hsp104 works synergistically 
with the Hsp70 chaperone system to not only resolubilize misfolded substrates, but to 
also restore their proper function (Glover and Lindquist, 1998). Interestingly, normal 
Hsp104 function is required in a yeast model to maintain different prion proteins in their 
12 
 
amyloid-like prion conformation (Chernoff et al., 1995; Derkatch et al., 1997; Moriyama 
et al., 2000; Sondheimer and Lindquist, 2000) by generating small prion seeds via 
fragmentation of larger prion aggregates which enables new rounds of prion propagation 
(Wegrzyn et al., 2001). Further in vitro studies demonstrated that Hsp104 couples ATP 
hydrolysis with the rapid disassembly of amyloid-like fibers and oligomeric intermediates 
formed by the yeast prions [PSI+] and [URE3] (Shorter and Lindquist, 2004; Shorter and 
Lindquist, 2006). Thus, it is not surprising that Hsp104 overexpression was able to 
efficiently solubilize amyloid-like aggregates formed by the expanded-polyQ huntingtin 
(Htt) fragment and reduce cell death in a yeast model (Cashikar et al., 2005). Yet removal 
of Hsp104 via gene deletion also subdued the toxicity caused by overexpression of the 
expanded-polyQ Htt fragment (Meriin et al., 2002). Thus, Hsp104 may indirectly affect 
polyQ aggregation and toxicity in yeast by acting through the yeast prions, [PSI+] and/or 
[RNQ+] [also termed [PIN+](Derkatch et al., 1997)], which can serve as Q/N-rich 
templates to alter the conformation of the expanded-polyQ protein into an aggregation-
prone, toxic form (Derkatch et al., 2004; Gokhale et al., 2005; Meriin et al., 2002).  
To clarify the role of Hsp104 in polyQ aggregation and toxicity, the yeast Hsp104 
chaperone was introduced into a number of higher eukaryotes and retained its ability to 
remodel amyloid-like assemblies. In a C. elegans model, expression of Hsp104 reduced 
the aggregation of expanded-polyQ proteins and abrogated developmental delays (Satyal 
et al., 2000). Similarly in a rat model, the presence of Hsp104 suppressed expanded-
polyQ toxicity in a manner which correlated with altered distribution and number of the 
polyQ assemblies (Perrin et al., 2007). The small heat shock proteins, Hsp26 in yeast and 
Hsp27 in rats, were identified as potentiators for Hsp104-mediated suppression of polyQ 
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aggregation and toxicity (Cashikar et al., 2005; Perrin et al., 2007). Utilizing a Parkinson 
disease model in rats, Hsp104 was also shown to antagonize the formation oligomeric 
intermediates and amyloid fibers by α-synuclein which reduced dopaminergic 
degeneration (Lo Bianco et al., 2008). Thus, molecular chaperones can act at multiple 
stages in the aggregation pathway to both coordinate the disassembly of amyloid-like 
aggregates and prevent the self-association of non-native protein monomers. 
 
1.3.3 Molecular chaperones participate in the degradation of proteotoxic substrates 
by the ubiquitin-proteasome system or chaperone-mediated autophagy 
Under certain conditions, chaperone machinery cannot repair the misfolded protein 
and must coordinate its degradation by either the ubiquitin-proteasome pathway or 
lysosomal-mediated autophagy. CHIP (carboxy terminus of Hsc70-interacting protein) is 
a versatile protein that acts as a co-chaperone to Hsc70 (Heat shock cognate 70) or 
Hsp70, possesses intrinsic chaperone activity in its own right and functions as an E3 
ligase to mediate the transfer of polyubiquitin chains to misfolded substrates (Cyr et al., 
2002; Jiang et al., 2001; Rosser et al., 2007). The Hsp70 interacting protein, Bag2 (Bcl2-
associated athanogene 2), can inhibit the ubiquitin ligase activity of CHIP and promote 
substrate refolding by Hsp70 (Arndt et al., 2005; Dai et al., 2005). Overexpression of 
CHIP increased the ubiquitination and degradation of expanded-polyQ huntingtin and 
ataxin-3, the causative gene for Spinocerebellar ataxia type 3 (SCA3) (Jana et al., 2005).  
This subsequently reduced polyQ aggregation levels and suppressed cell death. The 
suppressive activity by CHIP overexpression became more prominent when Hsc70 levels 
were also elevated. Similar results were obtained which demonstrated CHIP’s ability to 
14 
 
reduce aggregation of expanded-polyQ substrates and suppress cell death in transfected 
cell lines, primary neurons and zebrafish models (Miller et al., 2005). Therefore, CHIP 
along with other cofactors can partition Hsp70 substrates between refolding and 
degradation pathways.   
The autophagy pathway represents a mechanism independent of the ubiquitin-
proteosome system which participates in the intracellular bulk degradation of organelles 
as well as misfolded and aggregated proteins. Autophagy entails the 
packaging/engulfment of cytoplasmic contents into autophagosome vesicles which fuse 
with lysosomes, wherein the contents are degraded (Levine and Klionsky, 2004). Loss of 
autophagy in mice via disruption of ATG5 manifested features characteristic of 
neurodegeneration even in the absence of any disease-associated mutant proteins (Hara et 
al., 2006). Molecular chaperones have been shown to participate in the recognition and 
subsequent packaging of misfolded proteins into autophagasomes which has become 
termed chaperone-mediated autophagy (CMA) (Terlecky et al., 1991). CMA involves the 
selective targeting of proteins containing a KFERQ peptide motif to lysosomes (Olson et 
al., 1991). The rate-limiting step in CMA involves chaperone/cargo binding to the 
lysosomal receptor, Lamp2a (Cuervo and Dice, 1996). In this manner, chaperones can 
recognize misfolded or aggregated proteins and target them via the KFERQ motif to 
lysosomes for degradation. The causative agent in Parkinson’s disease, α-synuclein, 
possesses a pentapeptide sequence which is consistent with the CMA recognition motif 
and targets the disease protein to lysosomes (Cuervo et al., 2004). The pathogenic A53T 
and A30P mutations in α-synuclein were capable of binding the lysosomal receptors but 
inhibited both their own degradation as well as other substrates. Additionally, CMA has 
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also been linked to polyQ-expanded huntingtin toxicity through the small heat shock 
protein, HspB8, and Bag3. In cultured cells, elevated expression of HspB8 prevented the 
intracellular accumulation of polyQ-expanded huntingtin protein (Carra et al., 2005).  
Subsequent work demonstrated that HspB8 works in complex with Bag3 to stimulate the 
degradation of polyQ-expanded huntingtin protein by macroautophagy (Carra et al., 
2008). Thus, chaperones can couple their activity with multiple degradation pathways to 
remove toxic, disease proteins. 
 
1.4 Chaperones promote aggregation of toxic proteins 
 Chaperones are also capable of packaging disease proteins into tight, amyloid-like 
aggregates and thereby reducing the accumulation of soluble, oligomeric intermediates. 
Elevated expression of the human Hsp40, Hdj2, increased the aggregation of expanded-
polyQ huntingtin protein in COS-7 cells (Wyttenbach et al., 2000). Subsequent in vitro 
studies demonstrated that purified forms of Hsp70 and Hsp40, Hdj1, were able to 
attenuate polyQ oligomer assembly and drive the formation of amyloid-like fibrillar 
structures (Wacker et al., 2004). These data suggest that chaperones can partition disease 
proteins between oligomeric and fibrillar aggregation states. Chaperones other than 
Hsp70 and Hsp40 can take an active role in promoting protein aggregation.  The 
proteasomal chaperones, Rpt4 and Rpt6 (AAA ATPase subunits of the 19S proteasomal 
particle), facilitated the aggregation of different expanded-polyQ disease proteins, 
huntingtin and ataxin-3, without affecting proteasomal degradation (Rousseau et al., 
2009). Furthermore, in vitro reconstitution experiments showed that purified 19S 
proteasomal particles enhanced aggregation of expanded-polyQ huntingtin protein 
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(Rousseau et al., 2009). Thus, a number of molecular chaperones can promote the 
assembly of disease proteins into amyloid-like aggregates. 
 
1.4.1 Chaperone-mediated aggregation reduces proteotoxicity      
Recent work has begun to link chaperone-mediated aggregation of toxic proteins 
with suppression of toxicity. The chaperonin TriC complex was identified as potent 
suppressor of polyQ-mediated toxicity in C. Elegans (Nollen et al., 2004). This family of 
chaperonins form multi-subunit, cage-like structures that sequester non-native proteins 
(Fenton and Horwich, 2003) and work alongside Hsp70 chaperone systems to promote 
substrate refolding in the cytosol upon rounds of ATP hydrolysis (Farr et al., 1997; 
Frydman and Hartl, 1996). Substrate refolding occurs within the central cavity of the 
chaperonin complex and substrate release occurs after folding is complete (Meyer et al., 
2003). Interestingly, reducing the cellular concentration of TriC resulted in the 
accumulation of low-molecular weight, soluble oligomers by polyQ-expansions which 
correlated with toxicity in cell culture lines and yeast (Behrends et al., 2006; Kitamura et 
al., 2006; Tam et al., 2006). One group demonstrated by size exclusion chromotagraphy 
that toxic oligomers were approximately 200 kDa in size (Schaffar et al., 2004), yet the 
chaperonin complex remodeled the polyQ-expansions into higher molecular weight 
aggregates around the 500 kDa size range (Behrends et al., 2006). The ability of the 
chaperonin complex to remodel polyQ-expanded disease proteins worked synergistically 
with Hsp70, Ssa1, and Hsp40, Ydj1. In contrast, studies in [psi-] yeast demonstrate that 
excess Ydj1 increased aggregation of expanded-polyQ Htt, yet enhanced toxicity 
(Gokhale et al., 2005). Though these data seems contrary to the work done with TriC, the 
nature and size of the polyQ aggregates may differ between experimental conditions and 
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account for whether the polyQ protein elicits a toxic or benign outcome. Additionally, 
cellular factors such as endogenous prions add to complexity of how chaperone networks 
buffer the accumulation of expanded-polyQ aggregates in a yeast model. Nevertheless, 
this provides correlative evidence that chaperonin complexes can not only solubilize their 
substrates but also promote the efficient packaging of proteotoxic species into benign 
aggregates.   
Related studies in yeast have recently demonstrated the protective effects of Hsp40-
mediated aggregate formation. The Hsp40, Sis1, is an essential chaperone (Luke et al., 
1991) that participates in protein refolding (Lu and Cyr, 1998), protein translocation 
(Caplan et al., 1992), and translation initiation (Zhong and Arndt, 1993).  Sis1 activity is 
also required to maintain the Rnq1 yeast prion in its [RNQ+] amyloid-like, prion 
conformation (Sondheimer et al., 2001). Endogenous Rnq1 is not toxic to yeast yet 
modest elevation of Rnq1 levels induced cell death (Douglas et al., 2008). Rnq1 toxicity 
is dependent on the presence of pre-existing [RNQ+] prions as elevated Rnq1 levels are 
not toxic to [rnq-] cells in which the [RNQ+] prion conformer is absent. Thus, [RNQ+] 
prion seeds provide a template which can alter the conformation of native Rnq1 into a 
toxic form (Douglas et al., 2008). Elevating Sis1 levels was able to suppress Rnq1 
toxicity in a manner that correlated with increased formation of [RNQ+] prion assemblies 
and decreased amounts of soluble Rnq1. Point mutations (Rnq1 L94A) within the Sis1 
binding site of Rnq1 enabled it to assume an aberrant conformation which formed SDS-
soluble aggregates and became toxic in [rnq-] cells. Interestingly, Sis1 overexpression 
was able to detoxify excess Rnq1 L94A in [RNQ+] cells yet was unable to suppress Rnq1 
L94A toxicity in [rnq-] cells. Therefore, Sis1 detoxification requires [RNQ+] prion seeds 
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so that nascent Rnq1 can be efficiently packaged into benign, amyloid-like aggregates.  
Inefficiencies in the [RNQ+] prion assembly pathway due to compromised Sis1 activity 
exacerbated cell death.   
The molecular mechanism by which chaperones facilitate Rnq1 assembly into 
amyloid-like prions is not clear. Sis1 was previously shown to work in concert with 
Hsp104 to mediate the fragmentation of larger [RNQ+] prion aggregates (Aron et al., 
2007). This generates more [RNQ+] prion seeds and more nucleation points to further 
drive the autocatalytic conversion of nascent Rnq1 into the prion conformer.  The Ssa 
subclass of Hsp70 chaperones positively affects the formation and propagation of 
amyloid-like [PSI+] prions in yeast (Allen et al., 2005; Jung et al., 2000; Newnam et al., 
1999). Yet the role of Hsp70 in [RNQ+] prion assembly remains elusive. It does appear 
that [RNQ+] prion shearing alone is not sufficient to suppress Rnq1 toxicity as 
overexpression of Hsp104 or different Hsp70 members was unable to suppress Rnq1 
toxicity like excess Sis1 (Douglas et al., 2008). Therefore, we suggest that Sis1 may 
perform an additional function as an elongation factor in the [RNQ+] prion assembly 
process (Figure 1.3). Sis1 was shown to bind a region of Rnq1 outside the Q/N-rich prion 
domain (Douglas et al., 2008) in equimolar ratios (Lopez et al., 2003). Thus Sis1 may 
coat [RNQ+] prions and facilitate the stable association of nascent Rnq1 with [RNQ+] 
prions which would subsequently promote its efficient conversion into the growing 
amyloid-like [RNQ+] aggregate. Yet it is difficult to judge the relative importance of Sis1 
action in fragmentation versus elongation of [RNQ+] prions. 
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1.4.2 Distinct signaling pathways facilitate protein detoxification via opposing 
mechanisms 
Cells can manage the proteotoxic accumulation of soluble, oligomeric species by 
both disaggregation and aggregation methods. C. Elegans have become a valuable tool to 
dissect the dynamics of amyloid assembly pathways in aging organisms. Distinct 
signaling pathways exist which both prevent the formation of amyloid aggregates as well 
as promote efficient amyloid assembly. The heat shock factor-1 (HSF-1) signaling 
pathway promoted the solubilization of toxic, Aβ1-42 assemblies (Cohen et al., 2006). 
HSF-1 activity is induced by a variety of stress signals including heat-shock which 
subsequently promotes the expression of numerous chaperones (Morimoto, 1998; Sorger, 
1990; Wu et al., 1987). In contrast, the DAF-16 signaling pathway appears to promote 
efficient assembly of Aβ1-42 peptides into amyloid particles. The FOXO transcription 
factor, DAF-16 (Lin et al., 1997; Ogg et al., 1997), is a downstream target of 
insulin/insulin growth factor (IGF)-1-like signaling pathway which regulated life span 
and youthfulness in worms, flies and mammals (Kenyon, 2005). Although HSF-1 and 
DAF-16 signaling pathways promote longevity and cell survival, they appear to act by 
opposing mechanisms to accomplish this feat. 
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1.5 Conclusions 
Molecular chaperones can intervene at multiple points in the amyloid assembly 
pathway to buffer the proteotoxic accumulation of misfolded protein intermediates. As a 
first line of defense, chaperone networks can coordinate the solubilization and subsequent 
refolding or degradation of different toxic proteins. Alternatively, the cell possesses a 
second line of defense which can package misfolded proteins into benign aggregates and 
thereby minimize the cell’s exposure to the toxic assembly intermediates. Although the 
formation of amyloid-like aggregates appears to protect cells against protein misfolding 
events, the gradual stockpiling of amyloid fibrils into intra- and extra-cellular plaques can 
clearly have a negative impact on normal cellular processes over extended periods of 
time (Ehrnhoefer et al., 2008; Fiala, 2007; Lorenzo et al., 1994). Additionally, the general 
decline in protein homeostasis or proteostasis (Balch et al., 2008) by age or chronic stress 
may compromise chaperone networks (Morimoto, 2008) resulting in the destruction of 
benign aggregates and the generation of soluble, toxic oligomers. Two distinct signaling 
cascades appear to regulate the flux of misfolded, amyloidogenic proteins between 
solubilization and aggregation pathways (Cohen et al., 2006). HSF-1 regulates the 
expression of numerous molecular chaperones (Morimoto, 1998) and can antagonize 
aggregation through control of the integrated chaperone network. However, it is unclear 
in the DAF-16 signaling pathway which downstream components are involved in the 
remodeling of misfolded, disease proteins into ordered aggregates. Sis1 and the 
chaperonin complex were shown to drive protective aggregate formation, yet both 
proteins historically act to suppress non-specific aggregation (Frydman et al., 1992; Lu 
and Cyr, 1998). Therefore, different signaling pathways such as DAF-16 and HSF-1 may 
enable an individual chaperone such as Sis1 or the TriC chaperonin complex to perform 
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opposing functions on misfolded proteins. Alternatively, the disease substrate may 
possess intrinsic, structural properties which determine the action of the interacting 
chaperone. Further studies will elucidate the means by which opposing chaperone 
activities are regulated at a molecular and cellular level. 
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2.1 Abstract 
Protein conformational diseases are associated with the aberrant accumulation of 
amyloid protein aggregates, but whether amyloid formation is cytotoxic or protective is 
unclear. To address this issue, we investigated a normally benign amyloid formed by the 
yeast prion [RNQ+]. Surprisingly, modest overexpression of Rnq1 protein was deadly, but 
only when preexisting Rnq1 was in the [RNQ+] prion conformation. Molecular 
chaperones protect against protein aggregation diseases and are generally believed to do 
so by solubilizing their substrates. The Hsp40 chaperone, Sis1, suppressed Rnq1 
proteotoxicity, but instead of blocking Rnq1 protein aggregation, it stimulated conversion 
of soluble Rnq1 to [RNQ+] amyloid. Furthermore, interference with Sis1-mediated 
[RNQ+] amyloid formation exacerbated Rnq1 toxicity. These and other data establish that 
even subtle changes in the folding homeostasis of an amyloidogenic protein can create a 
severe proteotoxic gain-of-function phenotype and that chaperone-mediated amyloid 
assembly can be cytoprotective. The possible relevance of these findings to other 
phenomena, including prion-driven neurodegenerative diseases and heterokaryon 
incompatibility in fungi, is discussed. 
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2.2 Introduction 
 Alzheimer's disease, transmissible spongiform encephalopathies, and 
polyglutamine diseases are representatives of a large group of neurodegenerative 
disorders that are associated with the misfolding and conversion of particular proteins 
into amyloids (Carrell and Lomas, 1997). Amyloids form in response to many 
perturbations in protein homeostasis, namely mutations in the amino acid sequence of a 
disease-related protein, expansion of simple sequence elements in disease genes, elevated 
protein levels, and age-associated cell stress (Chiti and Dobson, 2006). Amyloid fibrils 
share a cross-β structural motif, in which β-strands run perpendicular to the long fiber 
axis and accumulate in intra- and extracellular inclusions (Caughey and Lansbury, 2003; 
Nelson et al., 2005). Fibril formation requires that a misfolded protein expose a pleated β-
surface that is capable of serving as a template and hydrogen-bonding partner with an 
extra β-strand (Carrell and Lomas, 1997). Biochemical parameters for the classification 
of protein aggregates as amyloids include resistance to solubilization by the detergent 
SDS and the ability to bind indicator dyes such as thioflavin-T (Chiti and Dobson, 2006).  
Amyloid deposits in the brain are a hallmark of protein conformational disease, 
but often there is only a poor correlation between the detection of amyloid fibrils and 
other markers of neurodegeneration (Haass and Selkoe, 2007). Thus, there is still intense 
debate about whether amyloids are the causative toxic protein species in 
neurodegenerative diseases. In fact, recent, still controversial work suggests that 
amyloids might be benign or cytoprotective and that difficult-to-characterize soluble 
oligomeric conformers are the toxic species of disease-causing proteins (Cheng et al., 
2007; Kayed et al., 2003; Shorter and Lindquist, 2005).  
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Cells buffer proteotoxic events related to intracellular protein misfolding via 
chaperone-mediated partitioning of nonnative conformers between pathways for proper 
folding, inclusion body formation, and degradation (Muchowski and Wacker, 2005). 
Molecular chaperones also play a critical role in the propagation of yeast prions 
(Chernoff et al., 1995), which are examples of intracellular amyloids that, in general, are 
not inherently toxic (Lindquist, 1997; Wickner, 1994). However, the conversion of active 
soluble Sup35 and Ure2 into their prion states [PSI+] and [URE3], respectively, 
inactivates these proteins (Lindquist, 1997; Wickner, 1994). Yeast prion formation occurs 
spontaneously at a low frequency, and the prion state is then perpetuated through the 
templating of newly synthesized prion proteins by preexisting amyloid-like prions (Chien 
et al., 2004). Templated prion proteins then undergo stable changes in structure and 
function to enter an amyloid-like state that is propagated and passed from mother cells to 
their daughters in a molecular chaperone-dependent manner (Chernoff et al., 1995). Yeast 
prions thereby constitute cytoplasmically transmitted, protein-based elements of 
inheritance that are dominant in genetic crosses (prions are denoted by brackets, italics, 
and capital letters to reflect these properties).  
The yeast prion [RNQ+] is determined by the conformational state of the Rnq1 
protein, which contains a C-terminal asparagine- and glutamine-rich prion domain and an 
N-terminal non-prion-forming domain (Derkatch et al., 2000; Sondheimer and Lindquist, 
2000). The native form of Rnq1 has no known normal biological function and is 
nonessential. Yet the [RNQ+] prion can have important effects on yeast cells because it 
influences certain other proteins to convert to amyloid-like states (Meriin et al., 2002; 
Osherovich and Weissman, 2001; Taneja et al., 2007). For example, [RNQ+] prions are 
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required for the initial conversion of native Sup35 to the [PSI+] state. Indeed, [RNQ+] 
constitutes the cytoplasmically inherited factor known as [PIN+] and is the only known 
yeast prion that is commonly found in wild strains (Derkatch et al., 2001; Nakayashiki et 
al., 2005). [RNQ+] prions also cause the exon 1 fragment of huntingtin protein, containing 
glutamine repeats, to become toxic in yeast (Meriin et al., 2002). Thus, [RNQ+] prions 
can interact with other amyloid-forming proteins and thereby help drive their conversion 
into benign or toxic amyloid-like species. 
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2.2 Results 
Overexpression of Rnq1 Is Toxic in [RNQ+] Cells  
We recently discovered that moderate (i.e., ≈5- to 10-fold) overexpression of 
Rnq1 from the GAL1 promoter was severely toxic in cells that harbored the [RNQ+] prion 
(Figure 2.1a, Upper panel shows growth of serially diluted liquid cultures on agar and 
Lower panel shows protein levels detected by western blot). This finding was surprising 
because Rnq1 overexpression was not toxic when endogenous Rnq1 was in the [rnq-] 
non-prion conformation, nor was it toxic in cells carrying a deletion of the RNQ1 gene, 
Δrnq1 (Figure 2.1a). Cell growth defects observed were more extreme than any we have 
observed with other misfolded proteins in yeast (Cooper et al., 2006; Duennwald et al., 
2006a; Duennwald et al., 2006b). At this modest level of Rnq1 overexpression, ≈25% of 
[RNQ+] cells were dead within 4 h, as determined by the percentage of colony-forming 
units and dye exclusion (data not shown). Toxicity was accompanied by the accumulation 
of Rnq1 aggregates that stained with the common amyloid diagnostic dye thioflavin-T 
(Figure 2.1b). Rnq1 overexpression was found to be toxic in [RNQ+] laboratory strains 
(W303, 74D-694, BY23, and BY4741), clinical strains (YJM269, YJM421, YJM436, and 
YJM653), a fermentation strain (Y12), and wine strains (I14, T73, and WE372) (M. 
Taipale and S.L., unpublished observations). Thus, Rnq1 toxicity is pervasive and not 
strain-specific.  
Although not quite as deadly, a carboxy-terminal Rnq1-YFP fusion protein 
behaved similarly to untagged Rnq1 and exhibited the same pattern of toxicity: toxic in 
[RNQ+] cells but not in [rnq-] or Δrnq1 cells. This result allowed us to correlate changes 
in toxicity with changes in protein distribution (Figure 2.1 and 2.2). While aggregated in  
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Figure 2.1 Overexpression of Rnq1 is toxic to [RNQ+] cells. (a) The effect of Rnq1 
overexpression on yeast cell viability in the presence and absence of the [RNQ+] prion. (b) 
Thioflavin-T staining of Rnq1 in [RNQ+], [rnq-] and ΔRnq1 cells.  Fixed yeast were decorated 
with α-Rnq1 sera that was detected with a fluorescent secondary antibody. The same cells were 
simultaneously stained with the amyloid indicator dye, thioflavin-T. (c) Visualization of the 
aggregation state of Rnq1-YFP by fluorescence microscopy. (d) The assembly status of Rnq1-
YFP as determined by SDD-AGE. The lower panels represent western blots of cell extracts 
probed with the indicated antibodies. 
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[RNQ+] cells, Rnq1-YFP was distributed throughout the cytosol in [rnq-] or Δrnq1 cells. 
Using low- and high-copy plasmids that express Rnq1-YFP at different levels, we found 
that toxicity positively correlated with the degree of overexpression (Figure 2.2a). 
Western blots of cell lysates separated by semidenaturing-detergent-agarose gel 
electrophoresis (SDD-AGE) demonstrated that, in [RNQ+] but not [rnq-] cells, Rnq1-YFP 
assembled into a SDS-resistant high-molecular-weight species typical of amyloid 
assemblies of yeast prions (Figure 2.1d and Figure 2.2b) (Kryndushkin et al., 2003). Yet 
a pool of soluble Rnq1-YFP, which ran at the position of a monomer on SDD-AGE gels, 
also was present in [RNQ+] cells.  
Growth of [RNQ+] cells overexpressing just the non-prion-forming domain or just 
the prion-forming domain of Rnq1, amino acids 1–153 and 154–405, respectively, was 
not hindered (Figure 2.2c). When the prion-forming domain is expressed on its own, it 
assembles into an SDS-resistant species that runs as an amyloid on SDD-AGE gels 
(Figure 2.2d). Therefore, the mechanism for Rnq1 toxicity does not appear related to the 
accumulation of large quantities of amyloid-like [RNQ+] prions per se.  
The toxicity of Rnq1 overexpression in the presence of the [RNQ+] prion might 
seem similar to the toxicity of overexpressed Sup35 in the presence of its prion [PSI+]. 
Overexpression of Sup35 is toxic in [PSI+] cells because it drives too much of the 
essential Sup35 protein into an inactive amyloid conformation (Derkatch et al., 1997). In 
contrast, Rnq1 toxicity cannot be due to an inhibition of Rnq1 function because deletion 
of the gene-encoding Rnq1 has no detectable effect on yeast growth under hundreds of 
conditions tested (T.F. Outeiro and S.L., unpublished data). Furthermore, in contrast to 
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Figure 2.2 Factors influencing Rnq1 toxicity include the expression level and presence of a 
carboxy-terminal tag. (a) Comparison of the toxicity of untagged Rnq1 to Rnq1-YFP that is 
expressed at different levels. (b) SDD-AGE analysis of the assembly status of Rnq1-YFP 
expressed from low and high copy expression vectors. The bottom panel represents Western blots 
depicting Rnq1-YFP levels in the indicated extracts. (c) The effect on growth of [RNQ+] yeast 
caused by overexpression of full length and truncated Rnq1-YFP fusion. Rnq1 1-153 corresponds 
to the Rnq1 N-terminal non-prion forming domain. Rnq1 154-405 corresponds to the Rnq1 C-
terminal prion forming domain. Spots that contain 10-fold serial dilutions of indicated yeast 
strains were positioned horizontally across the plate. The lower panel is a western blot of cell 
extracts that express the indicated YFP fusion with GFP anti-sera. (d) SDS-resistance of Rnq1-
GFP or PrD-GFP fusions expressed under control of the CUP1 promoter as analyzed by SDD-
AGE. 
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Sup35, expression of Rnq1's non-prion-forming domain does not rescue the toxicity 
caused by Rnq1 overexpression (data not shown). 
 
The Hsp40 Sis1 Can Suppress Rnq1 Toxicity 
Sis1, an essential Hsp40 chaperone, is required for the propagation of the [RNQ +] 
prion state (Sondheimer et al., 2001). Sis1 specifies Hsp70 function and is required for 
protein synthesis, protein folding, and cell stress protection (Fan et al., 2004; Zhong et al., 
1996). Overexpressing Sis1 by as little as 3-fold strongly suppressed Rnq1 toxicity 
(Figure 2.3a). To examine whether other chaperones were capable of suppressing Rnq1 
toxicity, an expression library of 4,954 yeast genes was screened (Cooper et al., 2006). 
Sis1 was the only chaperone in this library able to protect from Rnq1 toxicity (data not 
shown). This library includes, among many other chaperones, Ydj1, which is a member 
of the large Hsp40 family that is closely related to Sis1. It also includes Hsp70 Ssa1 
(Hsp70) and Hsp104, which assist in shearing [RNQ+] prions to form seeds required for 
the propagation of the [RNQ+] state (Aron et al., 2007). Therefore, the effect of Sis1 on 
the toxicity of Rnq1 overexpression is unique.  
Sis1 not only promotes [RNQ+] prion formation, but it remains stably bound to the 
prion in a 1:1 complex (Lopez et al., 2003). This finding could provide an explanation for 
the toxicity of overexpressed Rnq1: Elevation of [RNQ+] prion levels could kill cells by 
sequestering Sis1 away from its essential substrates. But this explanation is unlikely 
because cells in which Sis1 is depleted by nearly 100-fold grow for extended time periods 
and exhibit delayed lethality (Luke et al., 1991). In contrast, cells start to die within 4 h of 
the induction of Rnq1 overexpression.  
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To directly eliminate the possibility that cell death is due to the sequestration of 
Sis1, we deleted the domain of Sis1 that is required for interaction with the prion, the 
glycine- and phenylalanine-rich (G/F) region (Lopez et al., 2003). A Sis1 ΔG/F variant 
fails to promote the propagation of [RNQ+], but can carry out Sis1's essential functions. 
We overexpressed Sis1 ΔG/F and found that, unlike Sis1, it could not suppress Rnq1 
toxicity (Figure 2.3a). 
  
Sis1-Mediated Amyloid Formation Protects from Rnq1 Toxicity 
The toxicity produced by the overexpression of Rnq1 represents a dominant gain 
of function that requires endogenous Rnq1 protein to be in a [RNQ+] prion conformation. 
It may be Sis1's ability to facilitate [RNQ+] prion propagation that ameliorates Rnq1 
toxicity. Indeed, the suppression of Rnq1 toxicity by Sis1 overexpression was 
accompanied by a substantial increase in the formation of SDS-resistant [RNQ+] 
amyloids (Figure 2.3b). This seemed to be accompanied by a decrease in the pool of 
unassembled SDS-sensitive Rnq1. We have found, however, that although SDD-AGE is 
a reliable method for quantitatively detecting SDS-resistant species, it is not reliable for 
SDS-soluble species. To examine SDS-soluble species, we used gel-filtration 
chromatography. As shown in Figure 2.3c, a large pool of unassembled Rnq1-YFP 
accumulated on Rnq1-YFP overexpression (Figure 2.3c, compare Top and Middle). 
Suppression of Rnq1 toxicity by Sis1 correlated with a dramatic decrease in unassembled 
Rnq1-YFP pools and a corresponding increase in the pools of assembled forms (Figure 
2.3c, compare Middle and Bottom). These results suggest that cytotoxic Rnq1 conformers 
accumulate when levels of Rnq1 protein exceed the cell's capacity to efficiently promote 
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Figure 2.3 Sis1 overexpression protects against Rnq1 toxicity. (a) The effect of Sis1 
or Sis1ΔG/F overexpression on Rnq1 toxicity. (b) The effect of Sis1 overexpression on 
the formation of SDS-resistant [RNQ+] conformers as determined by SDD-AGE. (c) Gel 
filtration analysis of intracellular pools of overexpressed Rnq1-YFP. The lower panels in 
a and b represent Western blots of the indicated proteins. 
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the template-driven formation of the SDS-resistant [RNQ+] prion species. To test this 
hypothesis, we asked whether Rnq1 toxicity would be exacerbated when the efficiency of 
[RNQ+] amyloid assembly was reduced.  
 
Identification of the Sis1-Binding Site in Rnq1 
First, we identified and mutated the chaperone-binding motif that Sis1 uses to 
interact with Rnq1. A peptide array was created that contained 25 residue N-acetylated 
peptides spanning the entire Rnq1 amino acid sequence. This array was incubated with 
purified Sis1 and washed, and Sis1-interacting peptides were identified by western blot 
after transfer of bound chaperone to nitrocellulose (Figure 2.4b and 2.5a). Tight binding 
of Sis1 was observed only with a few neighboring Rnq1 peptides, and these peptides 
were located in the non-prion-forming domain.  
The amino acid sequence of this region is conserved in all known Rnq1 
homologues and contains a classic, hydrophobic, chaperone-binding motif, LGKLALL 
(Figure 2.5b and Figure 2.4a) (Rudiger et al., 2001). Hsp40 proteins stimulate the binding 
of their Hsp70 cochaperones to specific substrates. Indeed, Sis1 stimulated binding of its 
Hsp70 cochaperone, Ssa1, to the peptides containing this motif in an ATP-dependent 
manner (Figure 2.4b). Thus, Sis1 forms a functional chaperone:substrate complex with 
peptides containing this chaperone-binding motif.  
Next, to reduce the efficiency of Sis1's interaction with [RNQ+] prions, we 
replaced hydrophobic leucine residues in the Rnq1 chaperone-binding motif with alanines 
(L91A, L94A, and L97A). As demonstrated by coimmunoprecipitation, the capacity of 
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Figure 2.4 Sis1 binding to a conserved chaperone-binding motif in the non-prion domain of 
Rnq1. (a) A schematic showing the domain structure of Rnq1. The underlined region in non-
prion domain of Rnq1 represents a chaperone binding motif identified via screening a cellulose 
peptide array (see Fig. S2). (b) Sis1 dependent binding of Hsp70 Ssa1 to the peptide in the Rnq1 
peptide array that is bound most strongly by Sis1. (c) Mutation of L94A in the chaperone-binding 
motif reduces the ability of Sis1 to form co-immunoprecipitable complexes with Rnq1-GFP in 
[RNQ+] cells. Levels of the indicated proteins in c were visualized by western blot analysis (WB). 
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Figure 2.5 Mutation of the chaperone-binding motif slows the rate of Rnq1 assembly into 
[RNQ+] prions. (a) Peptide spots in a 25-residue Rnq1 peptide array that were bound by purified 
Sis1. Shown is a schematic of the Rnq1 peptide array in which circles represent the peptide spots 
starting at amino acid 1 of Rnq1 and sequentially shift in register by 3 amino acids until the 
terminal peptide. Filled circles represent peptide spots where Sis1 binding could be detected as 
significant levels above background. The darkness of the spots correlates with the intensity of 
Sis1 binding signal. (b) Comparison of the Sis1 binding site in Rnq1 with similar regions in the 
two known Rnq1 homologs from C. glabrata and E. gossypii.  The hydrophobic core within the 
peptide identified in b is conserved between species both in sequence as well as in proximity to 
the carboxy-terminal, Q/N rich prion-forming domain. The term aa is an abbreviation for amino 
acid. (c) Fluorescence microscopy of live [RNQ+] cells after the indicated form of Rnq1-GFP was 
expressed for 1 hr. (d) Pulse-Chase analysis of the assembly of nascent Rnq1 into pelletable 
[RNQ+] prions. [RNQ+] cells were labeled with 35S-translabel. At the indicated times cells were 
lysed and fractionated by centrifugation with an airfuge.  Rnq1-GFP present in supernatant and 
pellet fractions of cell extracts was then isolated by immuneprecipitation with α-GFP sera. 
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Rnq1-GFP to interact with Sis1 was strongly, but not completely, reduced by these 
mutations (Figure 2.4c and data not shown). 
  
Mutations in the Sis1-Binding Site of Rnq1 Interfere with [RNQ+] Amyloid 
Assembly  
To determine whether the Rnq1 chaperone-binding motif mutants were defective 
in the assembly of [RNQ+] amyloid, we expressed them as Rnq1-GFP fusions from an 
extrachromosomal plasmid in cells expressing WT Rnq1 in its prion state. The L91A, 
L94A, and L97A mutations were expressed at levels similar to those of WT Rnq1 by 
using the CUP1 promoter, but they had a reduced capacity to form fluorescent foci 
(Figure 2.5c). An L45A mutation, which also is located in the non-prion-forming domain, 
but lies outside of the chaperone-binding motif, had no detectable effect on the assembly 
of [RNQ+] prions. Further, a time-course analysis by SDD-AGE (Figure 2.6a) and pulse–
chase (Figure 2.5d) revealed that the rate at which newly synthesized Rnq1-GFP protein 
was converted into SDS-resistant conformers in vivo was reduced several fold by the 
L94A mutation in comparison with the WT protein. In addition, in vitro-purified Rnq1 
L94A could be templated by prion “seeds” present in [RNQ+] cell extracts to form SDS-
resistant species (Figure 2.6b). However, it was templated and converted to an SDS-
resistant form with lower efficiency than the WT Rnq1 protein.  
Finally, we asked whether the impairment of Rnq1 amyloid assembly increased 
the toxicity of Rnq1 overexpression. As we hypothesized, Rnq1 L94A was more toxic 
than WT Rnq1 when overexpressed in [RNQ+] cells (Figure 2.6c). A triple mutant, Rnq1  
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Figure 2.6 Mutations in the chaperone-binding motif of Rnq1 reduce the efficiency of 
[RNQ+] amyloid assembly. (a) Kinetics of Rnq1-GFP L94A assembly into SDS-resistant 
aggregates in [RNQ+] yeast determined by SDD-AGE. (b) [RNQ+] seed dependent assembly of 
purified Rnq1-His and Rnq1-His L94A into SDS-resistant amyloid. (c) Growth of 10 fold serial 
dilutions of [RNQ+] strains in which WT or L94A Rnq1 was overexpressed from the GAL1 
promoter.  Where indicated, Sis1 was overexpressed from the GPD promoter. Lower panels show 
the relative expression level of the specified proteins as determined by Western blot.   
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L94A–L96A–L97A, was even more toxic than Rnq1 L94A (data not shown). As 
expected from the fact that the Rnq1 L94A mutation impaired, but did not eliminate, 
interaction with Sis1, the overexpression of Sis1 3-fold was still able to suppress the 
toxicity of the mutant protein (Figure 2.6c).  
Thus far, we have shown that interfering with the assembly of Rnq1 into the 
[RNQ+] amyloid state is extremely toxic. Toxicity occurs when Rnq1 expression is higher 
than normal (Figures 2.1, 2.2 and 2.3) or when mutations in Rnq1 interfere with the 
efficiency of Sis1 interaction (Figures 2.4, 2.5 and 2.6). In addition, depletion of Sis1 
from the cytosol reduces the efficiency of [RNQ+] prion assembly and exacerbates Rnq1 
toxicity (Figure 2.7). These collective data indicate that the efficient conversion of native 
Rnq1 into its SDS-resistant amyloid form prevents the accumulation of a toxic Rnq1 
conformer. 
 
Suppression of Rnq1 Toxicity by Sis1 Requires [RNQ+] Prion Assembly  
Rnq1 L94A exhibits a higher propensity than WT Rnq1 to form SDS-soluble 
aggregates when [RNQ+] assembly is impeded via depletion of Sis1 (Figure 2.7). The 
inability of cells to maintain Rnq1 L94A in a soluble state correlates with the enhanced 
toxicity of the L94A mutant. In this sense, Rnq1 L94A is similar to alleles of 
amyloidogenic proteins whose subtle defects in folding kinetics cause devastating protein 
conformational diseases (Carrell and Lomas, 1997). Thus, we wondered whether Rnq1 
L94A would assume a toxic conformation in the absence of templating by [RNQ+] prion 
seeds. Indeed, the overexpression of Rnq1 L94A, but not WT Rnq1, was toxic in [rnq-] 
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Figure 2.7 Depletion of Sis1 hinders assembly of nascent Rnq1-GFP into SDS-resistant 
[RNQ+] aggregates. (a) The influence of Rnq1-GFP and Rnq1-GFP L94A overexpression on cell 
viability when Sis1 levels are normal or low. A [RNQ+] Δsis1 strain that harbored pGAL1-SIS1 
was grown on plates that contained galactose or glucose as the carbon source to maintain Sis1 at 
normal or low levels.  Rnq1-GFP and Rnq1-GFP L94A were expressed from the CUP1 promoter 
in the presence of 500 µM CuSO4. Sis1 was depleted from Δsis1 that was maintained pGAL1-
SIS1 from galactose to glucose medium. Consistent with a previous report (Luke et al., 1991), the 
near complete depletion of Sis1 did not cause yeast to exhibit growth defects on its own, but it did 
exacerbate Rnq1-GFP cytotoxicity. Further, this effect was far more severe for the L94A mutant 
than for wild-type Rnq1. (b) Coalescence of Rnq1-GFP and Rnq1-GFP L94A into foci in Sis1 
depleted cells. (c) SDD-AGE analysis of Rnq1-GFP and Rnq1-GFP L94A assembly into SDS-
resistant conformers at normal and low Sis1 levels.  The lower panels depict levels of the 
indicated proteins as determined by Western blot. These data demonstrate that the foci formed by 
Rnq1 L94A under toxic conditions are sensitive to SDS-treatment, and thus, do not appear to 
represent [RNQ+] prions. (d) Restoration of [RNQ+] prion formation in Sis1 depleted cells upon 
reintroduction of normal Sis1 expression. Bottom panels depict Sis1 and PGK levels in the 
indicated extracts as determined by western blot. Data in panel (d) indicate that defects in the 
assembly of Rnq1 and Rnq1 L94A into SDS-resistant species observed upon depletion of Sis1, 
are not resultant from curing [RNQ+] prion seeds from cells.   
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strains (Figure 2.8a). Hence, a small amino acid substitution can cause Rnq1 to be toxic 
even in the absence of [RNQ+] amyloid formation.  
Sis1-dependent [RNQ+] amyloid formation appears to protect cells from toxicity 
caused by the overexpression of Rnq1. If amyloid formation is a critical aspect of Sis1's 
ability to suppress Rnq1 toxicity, then Sis1 overexpression should not protect [rnq-] cells 
from Rnq1 L94A-mediated death because these cells lack the [RNQ+] prion seeds 
required for amyloid assembly. Indeed, overexpression of Sis1, which binds Rnq1 L94A 
with reduced efficiency, protected [RNQ+], but not [rnq-], strains from Rnq1 L94A 
toxicity. This finding further confirms that Rnq1 toxicity is not caused by the 
sequestration of Sis1 into [RNQ+] prion complexes. Furthermore, the presence of the 
[RNQ+] prion assembly pathway and Sis1 overexpression are both required for the 
suppression of Rnq1 toxicity. 
  
Rnq1 L94A Does Not Form Prion Amyloids in [rnq-] Cells  
To rule out the possibility that Rnq1 L94A assembled into [RNQ+] prions 
spontaneously in [rnq-] cells, we compared its assembly status to that of WT Rnq1 in 
[rnq-] strains (Figure 2.8b–e). In [rnq-] cells, Rnq1 L94A exhibited a higher propensity 
than WT Rnq1 to coalesce into foci (Figure 2.8b). Gel-filtration chromatography showed 
that Rnq1 L94A formed high-molecular-weight aggregates in these cells (Figure 2.9). 
Notably, these aggregates were not SDS-resistant and (Figure 2.8c) were unable to bind 
the amyloid indicator thioflavin-T (Figure 2.8d). Thus, Rnq1 toxicity is not related to the 
accumulation of excess pools of [RNQ+] amyloid and may be caused by a SDS-soluble 
Rnq1 species. 
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Figure 2.8 Rnq1 L94A toxicity and assembly status in [rnq-] yeast. (a) Growth of 10 fold 
serial dilutions of [rnq-] strains in which WT or L94A Rnq1 was overexpressed from the GAL1 
promoter. Sis1 was overexpressed from the GPD promoter. (b) Fluorescent foci formed by Rnq1-
YFP and Rnq1-YFP L94A in [RNQ+] and [rnq-] cells. (c) SDD-AGE analysis of aggregates 
formed by Rnq1-YFP and Rnq1-YFP L94A in [RNQ+] and [rnq-] cells. (d) Thioflavin-T staining 
of untagged Rnq1 and Rnq1 L94A in [RNQ+] and [rnq-] cells.  Fixed yeast were decorated with 
α-Rnq1 sera that was detected with a fluorescent secondary antibody. The same cells were 
simultaneously stained with the amyloid indicator dye, thioflavin-T. (e) Cell extracts from [rnq-] 
cells overexpressing either Rnq1 or Rnq1 L94A were incubated with purified Rnq1-His or Rnq1-
His L94A.  The assembly status of purified Rnq1-His was determined by SDD-AGE. As a 
control, the assembly status of purified Rnq1-His incubated with [RNQ+] cell extract was also 
determined. Lower panels in (a) and (b) are western blots of cell extracts. 
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Figure 2.9  Analysis of the mobility of Rnq1 L94A in extracts from [RNQ+] and [rnq-] strains 
by gel filtration chromatography.  Rnq1-YFP L94A was expressed from the GAL1 promoter 
for 4 hrs in the indicated strain.  Extracts were prepared under native buffer conditions and loaded 
onto a Superose 12S column. The mobility of Rnq1-YFP L94A was determined with Western 
blot of column fractions with anti-GFP sera. 
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Because small prion seeds in the form of detergent-soluble prefibrillar species could have 
escaped detection by SDD-AGE and thioflavin-T staining, we applied another test for the 
existence of such forms of Rnq1 L94A in [rnq-] cell extracts (Figure 2.8e). Prion seeds in 
cell extracts can be sensitively detected through their ability to catalyze the conversion of 
exogenously added native prion protein into SDS-resistant amyloids. Prion seeds were 
readily detected in lysates of [RNQ+] cells overexpressing Rnq1 L94A (Figure 2.6b). 
However, extracts of [rnq-] cells that contained toxic levels of Rnq1 L94A failed to seed 
assembly of purified His-Rnq1 or His-Rnq1-L94A into SDS-resistant amyloids (Figure 
2.8e).  
The Rnq1 L94A assemblies in [rnq-] cells fail to meet three classification 
standards of [RNQ+] amyloid. They are SDS-soluble, they do not stain with thioflavin-T, 
and they do not seed polymerization of soluble Rnq1 protein. Rnq1 L94A is more lethal 
than Rnq1 and can assume a toxic conformation in the absence of [RNQ+] templates. 
Rescue from Rnq1 L94A toxicity requires Sis1 overexpression and active propagation of 
the [RNQ+] prion. Therefore, it appears that the conversion of Rnq1 L94A to [RNQ+] 
amyloid prevents the accumulation of toxic Rnq1 conformer whose true nature remains 
obscure. 
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2.4 Discussion 
Our data suggest a model in which efficient chaperone-dependent conversion of 
soluble Rnq1 into SDS-resistant [RNQ+] amyloid is critical to prevent the formation of 
other toxic Rnq1 conformers. We demonstrate that toxic Rnq1 conformers accumulate in 
a nonamyloid form when [RNQ+] assembly is made inefficient by multiple means. We 
propose that nonproductive templating of Rnq1 monomers by [RNQ+] seeds predisposes 
Rnq1 to leave the amyloid pathway and accumulate as a toxic species, whose exact 
nature is not yet clear. Templating of native proteins to form amyloid is a basic feature of 
amyloidogenesis, and we suggest that inefficiencies in this process contribute to the 
proteotoxicity associated with certain protein conformational diseases. This templating 
model explains how amyloid formation can serve a protective function, whereas the 
[RNQ+] prion state is a prerequisite for toxicity of the WT Rnq1 protein.  
One of Sis1's functions in [RNQ+] prion propagation appears to be promoting the 
shearing of [RNQ+] amyloid fibers into smaller pieces, thereby creating new surfaces to 
more efficiently seed the assembly of the prion (Aron et al., 2007). This reaction also 
requires Hsp104 and Hsp70. Hence, binding of Sis1 to the non-prion-forming domain of 
full-length Rnq1 may help facilitate this shearing process. However, because 
overexpression of Hsp70 and Hsp104 does not suppress Rnq1 toxicity, Sis1 may have 
additional functions in [RNQ+] prion propagation that do not overlap with those of other 
chaperones. Sis1 stably associates with assembled [RNQ+] conformers in a 1:1 molar 
ratio (Lopez et al., 2003). Therefore, Sis1's binding to the non-prion-forming domain has 
the potential to stabilize [RNQ+] prions in a conformation that is optimal for efficient 
amyloid fibril growth.  
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Many neurodegenerative diseases involve the accumulation of intracellular and/or 
extracellular amyloid protein aggregates. In the past, these amyloid aggregates were 
thought to be the cytotoxic, disease-causing protein conformer. However, recent studies 
have begun to question this view. As one striking example in mice, deletion of the GPI 
anchor of the prion protein PrP leads to massive extracellular amyloid plaque formation 
in mice injected with infective scrapie, but causes no overt clinical manifestations of 
scrapie (Chesebro et al., 2005). Furthermore, it has been suggested that 
neurodegenerative diseases are caused by the ability of very different proteins to adopt 
common toxic nonamyloid conformers such as protofibrils or soluble oligomers 
(Caughey and Lansbury, 2003; Haass and Selkoe, 2007). Hence, amyloid formation may 
serve to convert oligomeric amyloid precursors into a highly stable, nontoxic form 
(Piccardo et al., 2007).  
Although amyloid is not toxic, its interaction with soluble protein forms could 
give rise to pathogenic species via nonproductive templating. Case in point, when GPI-
anchorless PrP was expressed together with WT PrP, it accelerated scrapie disease and 
resulted in increased deposits of both amyloid and nonamyloid proteinase K-resistant PrP 
(Chesebro et al., 2005). Similarly, in yeast, the toxicity of Huntington exon 1 depends on 
the [RNQ +] prion state (Duennwald et al., 2006a; Meriin et al., 2002). This concept may 
even extend to the heterokaryon incompatibility mediated by the [Het-s] prion in 
Podospora anserina (Coustou-Linares et al., 2001). HET-s in its prion form only leads to 
cell death when coexpressed with the HET-S allele that cannot form amyloid. Templating 
of the nonamyloidogenic HET-S protein by [Het-s] prion seeds could lead to the 
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formation of a toxic species, whereas templating of HET-s protein would result in the 
nontoxic prion amyloid species.  
The aggregation state and the toxicity of aggregation-prone proteins are strongly 
modulated by host factors such as Hsp70 and its associated cochaperones, but the 
mechanisms for chaperone function in this process are just being defined (Muchowski 
and Wacker, 2005). Molecular chaperones generally act to antagonize protein 
aggregation. Yet our observations that the chaperone-dependent assembly of amyloid 
conformers can be cytoprotective provide a different view of the effects of chaperones in 
conformational disease. Thus, molecular chaperones can antagonize protein toxicity in 
conformational disorders by two different mechanisms: They can solubilize misfolded 
proteins or aid in sequestering them into benign, amyloid-like species. The most central 
aspect of antagonizing toxicity of misfolded proteins appears to be preventing 
accumulation of the detergent-soluble misfolded species, rather than preventing the 
formation of amyloid conformers. 
   
61 
 
2.5 Materials and methods 
Strains and Plasmids. W303, MATa can1-100 ade2-1, his3-11,15 leu2-3,112 ura3-1 
trp1-1; W303Δrnq1, MATa can1-100 ade2-1 his3-11,15 leu2-3,112 ura3-1 trp1-1 
Δrnq1:KanMX4; 74D-694, MATa ade1-14 trp1-289 his3Δ-300 ura3-52 leu2-3,112; 
W303Δsis1, MATa ade2-1 his3-11,15 leu2-3,112 ura3-1 trp1-1 ssd1-d2 sis1::HIS 
pRS316-SIS1. All the above strains harbored Rnq1 in its [RNQ+] form and the generation 
of isogenic [rnq-] strains was accomplished via sequential passage of cells on plates 
containing 3 mM guanidinium-HCl (Eaglestone et al., 2000).  W303 and 74D-694 strains 
were utilized to take advantage of the different markers or gene deletions. Identical 
results were obtained in studies carried out with both of these strains, so Rnq1 toxicity is 
not strain specific.  
Strains were transformed with plasmids and cultured in synthetic media as 
previously described (Caplan and Douglas, 1991).  Plasmids that express the indicated 
protein under control of the GAL1 promoter include pRS416-RNQ1, pRS416-RNQ1-
YFP, and pYES3-SIS1, termed pGAL1-SIS1.  Plasmids that express RNQ1 under control 
of the CUP1 promoter include pRS316-RNQ1-GFP, pRS315-RNQ1-GFP.  The 
glyceraldehyde-3-phosphate dehydrogenase (GPD) promoter controlled expression of 
SIS1 in pRS414-SIS1 and pRS414-sis1Δg/f.  The QuikChange site-directed mutagenesis 
kit (Stratagene) was used to create the indicated point mutations in RNQ1. 
 
Analysis of Rnq1 cytotoxicity. W303 strains harboring pRS416-RNQ1 or pRS416-
RNQ1-YFP were grown overnight in synthetic drop-out media containing 2% raffinose 
before 5-fold serial dilutions were spotted on plates containing either 2% galactose or 
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glucose.  Alternatively, strains that harbored pRS316-RNQ1-GFP or pRS315-RNQ1-GFP 
were cultured overnight in synthetic media containing glucose before serial dilutions 
were spotted on agarose plates that contained 500 µM CuS04.  Plates were incubated for 
3-5 days at 30 ºC and then photographed. 
 
Screening of a Rnq1 peptide array. A 25mer Rnq1 cellulose bound peptide array was 
prepared by automated spot synthesis (Jerini Peptide Technologies). The array was 
screened according the manufactures instructions with 100 nM Sis1 or Hsp70 Ssa1 in the 
presence or absence of 1 mM EDTA or Mg-ATP.  Bound chaperones were transferred to 
a nitrocellulose membrane and the peptide spots were identified by western blot. Hsp70 
Ssa1 bound a number of different peptides that contained clusters of hydrophobic amino 
acids (data not shown), yet peptides 27-30 were the only peptides that Sis1 bound 
reproducibly with high affinity. In addition, peptide 28, which contains residues 82-106 
of Rnq1, was the only peptide that was bound by Hsp70 Ssa1 in a Sis1 and ATP 
dependent manner (Figure 2.5).   
 
Pulse-chase analysis of [RNQ+] prion formation. 74D-694 cultures were grown 
overnight in synthetic media and then diluted and starved in methionine free media. Log 
phase cultures were first supplemented with 50 µM CuS04 to induce Rnq1-GFP or Rnq1-
GFP L94A expression for 1 hr before the addition of Trans35S-label (100 µCi/ml).  
Cultures were labeled for 10 min, then 1 mg/ml of cold methionine was added and cells 
were washed. Cultures were incubated for the indicated time period at 30°C before 
samples were collected. Cell lysis was achieved by glass bead disruption in a buffer 
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composed of 50 mM Hepes pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Tween-20, 2 mM 
phenylmethysulfonyl fluoride and a protease inhibitor cocktail mixture. Cell debris was 
removed and the resulting lysate was spun at 4 ºC at 165,000 × g for 45 min in a TLA-
100 rotor (Beckman Coulter). Rnq1-GFP present in the supernatant and pellet fractions 
was then immuneprecipitated with α-GFP (Roche) in the presence of 0.1% SDS. 35S-
labeled proteins in immuneprecipitates were resolved by SDS-PAGE and detected by 
autoradiography.  
 
Analysis of [RNQ+] prion formation by fluorescence microscopy. To examine the 
assembly of newly synthesized Rnq1 into of [RNQ+] prions Rnq1-GFP expression was 
induced from the CUP1 promoter by the addition of 50 µM CuSO4 to log-phase cultures 
and live cells were photographed 1 hr later. To examine the aggregation pattern of Rnq1, 
Rnq1-GFP or Rnq1-YFP under condition where growth defects are observed, protein 
expression under control of the CUP1 or GAL1 promoter was induced by the addition of 
either 500 µM CuSO4 or 2% galactose, respectively, and 4 hrs later live cells were 
photographed. 
  Indirect immunofluorescence of Rnq1 and thioflavin-T staining of Rnq1 
aggregates were performed as follows. Log phase cells harboring pRS416-RNQ1 that 
were cultured in synthetic raffinose media were supplemented with 2% galactose for 4 
hrs to induce expression of either Rnq1 or Rnq1 L94A. Cells were fixed with 4% 
formaldehyde for 1 hr and washed twice in buffer containing 1.2 M sorbitol before being 
converted to spheroplasts via 45 min incubations at 30ºC in the presence of 5 mg/ml 
zymolyase-20T. Cells were then permeabilized in phosphate buffer saline (PBS) 
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containing 0.1% Triton X-100 for 5 min. Cells were washed and incubated with PBS that 
contained 0.001% Thioflavin-T for 10 min. Next, thioflavin-T stained cells were washed 
4 times and incubated in PBS containing 1.0% BSA and 0.025% Triton X-100. Blocked 
cells were then incubated with polyclonal rabbit α-Rnq1 (1:50 dilution) for 1 hr and then 
washed 4 times. Cells were then decorated with goat α-rabbit conjugated Texas Red 
(1:1000) second antibody (Molecular Probes). Decorated cells were spotted on glass 
slides and photographed with a Nikon fluorescence microscope and images were 
processed with Metamorph and Adobe Photoshop Software. 
 
Semi-denaturing detergent agarose gel electrophoresis (SDD-AGE). Rnq1 assembly 
into SDS-resistant [RNQ+] prions was monitored by SDD-AGE as previously described 
(Kryndushkin et al., 2003) with the following exceptions. Cells were lysed in buffer 
containing 2% SDS, 5% glycerol, 75 mM Tris-HCl pH 6.8, 2 mM EDTA, 8% 2-
mercaptoethanol, 0.05% coomassie blue, 2 mM phenylmethysulfonyl fluoride and a 
protease inhibitor cocktail (Roche). Proteins resolved by the 1.5% agarose gel were 
electrophoretically transferred to PVDF in a submerged transfer apparatus for 2 hrs at 24 
V. PVDF membranes were then decorated with α-GFP and bands were visualized with 
ECL reagent.  
 
Rnq1 co-immunoprecipitation. Expression of Rnq1-GFP in log phase cells harboring 
the indicated form of pRS316-Rnq1-GFP was induced by supplementation with 50 µM 
CuSO4. Cell extracts were prepared 1 hr later under the non-denaturing conditions 
described above for the pulse-chase analysis. Cell debris was removed by centrifugation 
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and the resulting supernatant was supplemented with either α-Sis1 or α-GFP. Samples 
were incubated at 4ºC for 1 hr before being supplemented with pre-blocked protein G 
agarose beads. After 1 hr, the beads were isolated by centrifugation and washed 3 times 
with lysis buffer. Immuneprecipitated proteins were resolved by SDS-PAGE and detected 
by western blot.   
 
Rnq1 toxicity and [RNQ+] assembly in Sis1 depleted cells.  A strain in which Rnq1-
GFP expression was controlled by the CUP1 promoter and Sis1 expression was 
controlled the GAL1 promoter was constructed by transforming W303∆sis1 with 
pRS315-Rnq1-GFP and pGAL1-SIS1. To examine [RNQ+] toxicity at different Sis1 
levels, strains were generated by the plasmid shuffle technique (Boeke et al., 1987) and 
then grown on synthetic drop-out plates containing 2% glucose. A single colony was 
picked, diluted into sterile H20 and 5-fold serial dilutions were spotted onto plates 
containing either galactose or glucose in the presence of 500 µM CuSO4. To examine the 
effect that depletion of Sis1 had on [RNQ+] assembly, transformants grown on galactose 
plates were transferred to liquid media containing either glucose or galactose and cultured 
overnight at 30ºC. Cells were then diluted and grown an additional 12 hrs. Rnq1-GFP 
expression was then induced by the addition of 500 µM CuSO4 and the formation of 
SDS-resistant [RNQ+] particles was measured by SDD-AGE. To demonstrate that Sis1 
depleted cells were still capable of [RNQ+] prion assembly, Sis1 levels were restored by 
spotting cells cultured in glucose media back onto synthetic galactose plates. After the 
restoration of Sis levels, [RNQ+] assembly was monitored as described by SDD-AGE. 
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Seeded polymerization of purified Rnq1. His-Rnq1 WT and L94A were expressed 
from pDEST17 vector in BL21 cells for 4 hrs at 30 ºC followed by lysis in a buffer that 
contained 6 M guanidium-HCl and 100 mM  potassium phospate buffer pH 7.0. His-
Rnq1 was purified by standard techniques on Ni-NTA agarose that was washed with 8 M 
urea and 100 mM potassium phosphate buffer pH 7.0. His-Rnq1 was eluted with the 
same buffer at pH 3.0, concentrated by methanol precipitation and stored at -80 °C. Prior 
to use His-Rnq1 was resuspended in 6 M guanidium-HCl and filtered through a Microcon 
YM-100 spin-column. Yeast extracts containing [RNQ+] seeds were prepared as follows. 
The indicated form of Rnq1 was expressed from the GAL1 promoter for 4 hrs. Cells were 
isolated by centrifugation and extracts were created by bead disruption in buffer 
composed of 40 mM Hepes, pH 7.5, 150 mM KCL, 2 mM DTT, 5% glycerol, 8 mM 
PMSF, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. An aliquot of purified Rnq1 was 
adjusted to a final concentration of 5 µM in cell lysate and incubated at 25 ºC for 30 min, 
without agitation. Samples were then analyzed by SDD-AGE described above. 
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Hsp40 dependent localization of [RNQ+] prions to the nucleus 
reciprocally effects Rnq1 and Huntingtin toxicity 
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3.1 Abstract 
Cellular environment influences whether misfolded disease proteins are benign or 
toxic. Yet, how the cellular milieu impacts detoxification of disease proteins is unclear. 
Herein we demonstrate that interplay between chaperone systems, nucleocytoplasmic 
traffic, and protein interaction networks impacts the efficiency of benign aggregate 
formation and proteotoxicity. Increasing Hsp40 chaperone activity shifted the site of 
[RNQ+] prion assembly from the cytosol to the nucleus. Nuclear Rnq1 was less toxic as 
its assembly into benign [RNQ+] prions was more efficient. [RNQ+] prions are 
environmental factors that act via an ill-defined mechanism to promote toxicity of a 
huntingtin’s protein exon-1 fragment with an expanded polyglutamine tract (Htt-103Q). 
[RNQ+] prions were found to form stable complexes with Htt-103Q, which enabled 
nuclear [RNQ+] prions to attract Htt-103Q from the cytosol to the nucleus. The efficiency 
of nuclear Htt-103Q assembly into SDS-resistant aggregates was dramatically reduced 
and this exacerbated Htt-103Q toxicity. Molecular chaperones directly and indirectly 
impact the cellular location of amyloid-like aggregate formation. This has a profound 
impact on proteotoxicity because the cytosol and nucleus have different capacities to 
package disease proteins into benign assemblies. 
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3.2 Introduction 
Protein misfolding and accumulation of amyloid-like aggregates are the hallmarks 
of a broad class of protein conformational diseases, which include Alzheimer’s Disease, 
frontotemporal dementia, spongiform encephalopathies and polyglutamine expansion 
diseases (Carrell and Lomas, 1997). Factors that initiate protein aggregation and disease 
onset include inheritance of a mutant protein, aberrant protein processing, expansion of 
glutamine or alanine-rich tracts of amino acids, and environmental stress (Chiti and 
Dobson, 2006). The amino acid sequence of individual, disease-causing proteins defines 
the neurodegenerative disorder as well as the affected brain regions. Though it is unclear 
why some neuronal populations are more vulnerable to toxicity while others are more apt 
to efficiently manage protein misfolding events (Taylor et al., 2002). The differential 
susceptibility of various neuronal subtypes to proteotoxicity indicates that the cellular 
environment plays a major role in dictating whether a misfolded disease protein is toxic 
(Balch et al., 2008).   
The exact nature of the neurotoxic conformer formed by individual, disease 
proteins remains controversial (Caughey and Lansbury, 2003). Aggregates formed by 
disease proteins can sequester essential cellular proteins (Burke et al., 1996; Steffan et al., 
2000) and/or inhibit the activity of the proteasome (Bence et al., 2001) and thereby cause 
cell death. Yet, the extent of disease protein aggregation does not always correlate with 
the observed pathology (Caughey and Lansbury, 2003; Haass and Selkoe, 2007) and 
small oligomers formed by disease proteins have been implicated as the toxic species 
(Haass and Selkoe, 2007; Kayed et al., 2003).  
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A primary mechanism to prevent the accumulation of toxic protein species is 
chaperone-dependent suppression of disease protein aggregation and subsequent 
degradation (Cohen et al., 2006; Muchowski and Wacker, 2005). Emerging evidence 
demonstrates that the conversion of disease proteins into ordered, benign aggregates also 
serves to prevent the accumulation of toxic protein oligomers (Behrends et al., 2006; 
Cheng et al., 2007). Paradoxically, the ability of disease proteins to assemble into ordered 
benign aggregates is critically dependent upon molecular chaperone action (Behrends et 
al., 2006; Douglas et al., 2008). Thus, molecular chaperones can protect against 
proteotoxicity by either suppressing or promoting protein aggregation.   
Cell stress or subtle age-dependent changes in the activity of chaperone networks 
appear to enable pools of disease proteins to escape surveillance and accumulate as toxic 
conformers (Morimoto, 2008). Epigenetic factors control molecular chaperone expression 
and the capacity of chaperone networks in different cell types and subcellular 
compartments is variable (Balch et al., 2008; Morimoto, 2008). Therefore, selective 
vulnerability to conformational disease could result from differences in the neuron’s 
ability to promote efficient flux of disease proteins through degradation and aggregation 
pathways.  
The cytosol and nucleus have different capacities to buffer the presence of mutant 
disease proteins, but the mechanism behind this occurrence is unknown (Ross, 1997). For 
example, normal Huntingtin protein (Htt) contains a 25-residue polyglutamine (polyQ) 
sequence within exon I and predominately resides within the cytosol (De Rooij et al., 
1996). Huntington’s disease is caused by the expansion of the polyQ region in Htt 
beyond 39 residues and is associated with the nuclear accumulation of mutant Htt in 
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striatal neurons (DiFiglia et al., 1997; Saudou et al., 1998). Conversion of mutant Htt to a 
toxic species in the nucleus may occur through its interactions with new nuclear 
neighbors (Duennwald et al., 2006). In addition, the cytoplasmic chaperonin TriC, which 
functions to assemble mutant Htt into benign aggregates (Behrends et al., 2006), is not 
the present in the nucleus (Kim et al., 1994). Therefore, when mutant Htt enters the 
nucleus, it appears to face a combination of negative environmental influences that 
enable it to assume a toxic conformation. However, attaining a mechanistic 
understanding of the environmental conditions that permit accumulation of toxic Htt 
species requires further study. 
To define how the cellular environment buffers the accumulation of proteotoxic 
species, we study features of Rnq1 prion and Htt toxicity in yeast. The yeast prion Rnq1 
belongs to a class of glutamine/asparagine-rich (Q/N) proteins that exist in native and 
alternate, self-propagating amyloid-like forms (Sondheimer and Lindquist, 2000). 
Though benign at low levels, elevated expression of Rnq1 protein induces cell death 
(Douglas et al., 2008). Formation of toxic Rnq1 species requires the presence of pre-
existing [RNQ+]/[PIN+] prions (Derkatch et al., 1997; Douglas et al., 2008). Rnq1 
toxicity is suppressed by increasing the levels of the Hsp40 chaperone, Sis1, which 
enhances [RNQ+] prion formation and reduces accumulation of a detergent-soluble Rnq1 
species (Douglas et al., 2008). These data demonstrate that chaperone-dependent 
conversion of a toxic protein into its amyloid-like prion can serve as a protective 
mechanism. In addition, the efficiency of disease protein flux through amyloid assembly 
pathways appears to strongly influence whether or not cells tolerate disease protein 
expression. 
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 [RNQ+] prions also represent a model system to study the mechanism by which 
environmental factors promote the conversion of disease proteins to a toxic state (Meriin 
et al., 2002). It is proposed that [RNQ+] prions expose surfaces that serve as templates 
that foster conversion of endogenous yeast prions and foreign prions from other 
organisms, which are expressed in yeast, into amyloid-like states (Derkatch et al., 1997; 
Taneja et al., 2007). Furthermore, [RNQ+] prions act via an unknown mechanism to 
facilitate the conformational switching of the polyQ expanded exon-1 fragment from 
Huntingtin’s protein (Htt-103Q) from a benign to toxic state (Meriin et al., 2002). Thus, 
the study of interactions between [RNQ+] prions and Htt-103Q provides an excellent 
model to understand how members of a disease protein’s neighborhood influence 
whether it becomes benign or toxic. Such information will help explain enigmatic 
observations of selective neuronal vulnerability to specific disease proteins.  
To investigate how a disease protein’s environment influences its toxicity, we 
examined the impact of relocating [RNQ+] prions from the cytosol to the nucleus on cell 
death caused by Rnq1 and Htt-103Q. Hsp40 dependent accumulation of Rnq1 in the 
nucleus dramatically enhanced the accumulation of [RNQ+] prions and suppressed Rnq1 
toxicity. Relocation of the [RNQ+] prion assembly pathway from the cytosol to the 
nucleus also had dramatic effects on Htt-103Q localization and toxicity. Nuclear [RNQ+] 
prions sequestered Htt-103Q and interfered with the formation of SDS-resistant, Htt-
103Q aggregates. The resultant accumulation of detergent-soluble forms of Htt-103Q 
correlated with a dramatic increase in Htt toxicity. The presence of [RNQ+] prions in the 
nuclear environment reciprocally impacts the toxicity of Rnq1 and Htt-103Q. The 
differences in toxicity tightly correlate with the ability of the cytosol and the nucleus to 
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package Rnq1 and Htt-103Q in SDS-resistant aggregates. These data demonstrate that the 
capacity of the cytosol and nucleus to package proteins into benign aggregates varies in a 
manner that is dependent upon the nature of individual disease proteins. 
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3.3 Results 
Sis1-mediated suppression of Rnq1 toxicity is accompanied by movement of [RNQ+] 
prions the nucleus 
To explore how changes in chaperone activity within the cellular environment 
impact toxicity of disease proteins, we examined the ability of the Hsp40 Sis1 to subdue 
the rapid onset of Rnq1 toxicity in relation to the subcellular distribution of the [RNQ+] 
prions. The yeast plasma membrane becomes permeable to sytox dye (Zakrzewska et al., 
2007) within 5 hrs of inducing Rnq1 overexpression (Figure 3.1a). Elevating Sis1 
expression within the physiologic levels observed during heat-stress (Bardwell et al., 
1986), prevents Rnq1 from permeablizing the yeast plasma membrane to sytox, which 
correlates with suppression of Rnq1 induced cell death (Douglas et al., 2008). 
Interestingly, Sis1-dependent suppression of Rnq1 toxicity was also associated with a 
dramatic change in the localization of fluorescent [RNQ+] prion foci containing Rnq1-
mRFP from the cytosol to the nucleus (Figure 3.1b). 
The link between suppression of Rnq1 toxicity by Sis1 and the relocation of 
[RNQ+] prions to the nucleus is intriguing because, until now, changes in the 
nucleocytoplasmic distribution of disease-causing proteins has been associated with the 
onset of cell death (DiFiglia et al., 1997; Neumann et al., 2006; Saudou et al., 1998). 
Type II Hsp40s such as Sis1 have been implicated in mediating the accumulation of a 
range of proteins in the nucleus (Cheng et al., 2008; Zhang et al., 2008). Thus, we sought 
to establish the concept that molecular chaperones can impact proteotoxicity by 
influencing the cellular location of a disease protein.   
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Figure 3.1 Suppression of Rnq1 toxicity by Sis1 correlates with nuclear accumulation of 
[RNQ+] prions. (a) Sytox dye uptake into cells expressing Rnq1 with and without excess Sis1. 
Rnq1 overexpression was induced for 5 hrs prior to the addition of sytox dye, at which point 
fluorescent readings were taken every min for 30 min. (b) Localization of Rnq1-mRFP in the 
nucleus resultant from Sis1 overexpression. Nup49-GFP is a marker of the nuclear envelope 
boundary. DAPI denotes the localization of nuclear DNA. (c) The effect of chaperone 
overexpression on the cellular distribution of Rnq1-GFP. (d) Western blot analysis of the 
indicated proteins from cell extracts in panel c.  
80 
 
Control studies demonstrate that the effect of Sis1 on [RNQ+] prion localization 
was a specific result of Sis1 action in Rnq1 detoxification. The Hsp70, Ssa1, as well as 
Hsp104 play important roles in [RNQ+] prion propagation (Schwimmer and Masison, 
2002; Sondheimer and Lindquist, 2000), but do not suppress Rnq1 toxicity (Douglas et 
al., 2008). Accordingly, overexpression of either of these chaperones did not detectably 
alter the subcellular distribution or expression level of Rnq1-GFP (Figure 3.1c and d). In 
addition, elevating Sis1 levels did not have a pleiotrophic effect on nucleocytoplasmic 
traffic. Sis1 overexpression did not alter the cellular location of GFP (Figure 3.1c, right 
column), [PSI+] prions formed by Sup35-GFP (Figure 3.2a), or a GFP reporter of 
nucleocytoplasmic transport that contains both NLS (nuclear localization signal) and 
NES (nuclear export signal) moieties (Figure 3.2b) (Stade et al., 1997).   
Eukaryotic cells clear some misfolded protein conformers from the cytosol by 
partitioning protein aggregates into aggresome-like assemblies (Johnston et al., 1998) and 
non-aggregated ubiquitinated proteins to a perinuclear compartment for degradation 
(Kaganovich et al., 2008). Our data suggest that an additional route for detoxification 
exists, so it was important to further demonstrate that detoxification of Rnq1 was actually 
dependent upon nuclear transport machinery. This was accomplished by identification of 
three nuclear pore proteins (Nup84, Nup120, Nup188) and one nuclear transport receptor 
(Kap123) whose deletion hindered the ability of Sis1 to promote nuclear [RNQ+] prion 
accumulation (Figure 3.3a). These same nuclear import pathway genes were also shown 
to be required for Rnq1 detoxification in the absence of Sis1 overexpression because their 
deletion enhanced Rnq1 toxicity (Figure 3.3b). Thus, Rnq1 toxicity is exacerbated by 
removal of nuclear protein import machinery that is required for Sis1-  
81 
 
 
Figure 3.2 Sis1 overexpression does not promote the nuclear accumulation of [PSI+] prions 
or a nucleocytoplasmic transport reporter protein. (a) The localization of Rnq1-GFP or 
Sup35-GFP was monitored in [RNQ+][PSI+] cells by fluorescence microscopy. Right panels show 
prion localization in the presence of Sis1 overexpression. (b) Model of the tandem GFP reporter 
protein with an N-terminal NLS and NES. The cellular distribution of NLS-NES-GFP was 
monitored in the presence or absence of Sis1 overexpression by fluorescence microscopy. DAPI 
stained images were overlaid with the GFP channel in the merge.     
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Figure 3.3 Identification of nuclear import factors that are required for Sis1-mediated 
concentration of Rnq1-GFP to the nucleus. (a) Deletion strains of 24 non-essential nuclear 
transport factors were sequentially transformed with plasmids expressing Sis1 and then Rnq1-
GFP. The localization of Rnq1-GFP in 200 cells from 3-5 different transformations was scored 
via fluorescence microscopy as in Figure 3.1c. Deletion strains in which there was a significant 
decrease in Sis1 dependent nuclear accumulation of Rnq1-GFP are indicated (*), which denotes a 
p-value of <0.005. (b) Exacerbation of Rnq1 toxicity via deletion of genes required for Sis1 
dependent nuclear Rnq1 accumulation. Analysis of toxicity in 5 fold serial dilutions of cells 
grown on plates supplemented with galactose to induce Rnq1 expression from the GAL1 
promoter.   
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dependent [RNQ+] prion accumulation in the nucleus. These data, combined with Rnq1 
localization data, indicate that Sis1 does not drive [RNQ+] prion accumulation in 
cytosolic aggresomes or JUNK compartments (Johnston et al., 1998; Kaganovich et al., 
2008).  Instead, Sis1 somehow promotes [RNQ+] prion accumulation in the nucleus and 
this event assists in Rnq1 detoxification.  
Significant pools of Sis1 are normally found in the nucleus (Luke et al., 1991), so 
we explored the possibility that elevating Sis1 levels changes Rnq1 localization by 
stimulating nuclear [RNQ+] prion assembly. To test this concept, the order of Rnq1-GFP 
and Sis1 expression was varied and the effect of Sis1 overexpression on the localization 
of [RNQ+] prions was examined (Figure 3.4). When Rnq1-GFP was expressed first, 
[RNQ+] prions accumulated in the cytosol, and subsequent Sis1 overexpression did not 
redistribute [RNQ+] prions to the nucleus (Figure 3.4a and b). However, when Rnq1-GFP 
was expressed first, subsequent Sis1 overexpression was still able to suppress Rnq1 
toxicity (data not shown), because it stimulated [RNQ+] prion assembly (Douglas et al., 
2008). In contrast, when Sis1 levels were elevated prior to Rnq1-GFP expression, the 
nuclear accumulation of [RNQ+] prions was evident (Figure 3.4a and b).  
These data indicate that Sis1 does not drive the relocation of pre-formed, Rnq1-
GFP prion aggregates from the cytosol to the nucleus.  In addition, the ratio of Sis1 to 
[RNQ+] prion helps control whether the bulk of [RNQ+] prion assembly occurs in the 
cytosol or nucleus.  When cytosolic levels of [RNQ+] prions are high, [RNQ+] prion 
assembly is favored in the cytosol.  Yet, when the ratio of Sis1 to cytosolic [RNQ+] prions 
is elevated, Sis1 appears to promote the assembly of soluble Rnq1-GFP into nuclear 
[RNQ+] prions that are incapable of export back to the cytosol.  Over time, this Sis1  
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Figure 3.4 Sis1 overexpression needs to precede Rnq1-GFP expression to observe the 
nuclear localization of [RNQ+] prions. (a) Fluorescent images of the cellular distribution of 
Rnq1-GFP.  Sis1 was expressed from the GAL1 promoter while Rnq1-GFP was under control of 
the CUP1 promoter. The expression order of each protein was designated as 1st or 2nd. (b) 
Quantitation of Rnq1-GFP nuclear compartmentalization populations of 200 cells from 3 separate 
transformations. Values are expressed in percent of total cells counted and the error bars reflect 
the standard deviation. The p-value was <0.0001. (c) Expression levels of the indicated proteins 
by western blot analysis. 
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action shifts the localization of the [RNQ+] prion assembly pathway from the cytosol to 
the nucleus.  Thus, changes in the ratio of Rnq1 and Sis1 levels have dramatic effects on 
whether amyloid-like aggregate assembly occurs within the cytosol or the nucleus.  
 
The nuclear environment favors [RNQ+] prion accumulation  
To separate Sis1 action in [RNQ+] prion assembly from its impact on Rnq1 
localization, we compared the toxicity of Rnq1-GFP and Rnq1-GFP L94A to that of 
Rnq1-GFP-NLS and Rnq1-GFP-NLS L94A. The later has the SV-40 NLS (Kalderon et 
al., 1984) fused to the C-terminus of the GFP moiety attached to the C-terminus of Rnq1. 
The Rnq1 L94A variant was employed because it contains a point mutation in the Sis1 
binding site in the non-prion domain of Rnq1 (Douglas et al., 2008). Rnq1 L94A is a 
highly toxic Rnq1 variant because it’s conversion into amyloid-like [RNQ+] prions is 
inefficient (Douglas et al., 2008). Rnq1-GFP-NLS and Rnq1-GFP-NLS L94A were 
expressed at levels similar to their non-NLS-tagged counterparts, but were dramatically 
less toxic (Figure 3.5a). Decreased toxicity of NLS-tagged Rnq1-GFP and Rnq1-GFP 
L94A correlated with their accumulation in the nucleus (Figure 3.5b). It should be noted 
that near complete nuclear accumulation of Rnq1-NLS required it’s conversion into its 
[RNQ+] prion form, as it was enriched in the nucleus, but still present in the cytosol of 
[rnq-] cells (Figure 3.5b). Interestingly, filter trap and SDD-AGE analysis demonstrated 
that SDS-resistant pools of NLS-tagged forms of Rnq1-GFP and Rnq1-GFP L94A 
accumulated to 1.5 fold higher levels than the non-NLS-tagged forms (Figure 3.6a-c). 
Analysis of similar cell extracts by size exclusion chromatography demonstrated that 
around 55% of total Rnq1-GFP behaved as a high molecular weight species and the other  
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Figure 3.5 Rnq1-GFP-NLS is less toxic than Rnq1-GFP. (a) Analysis of toxicity in 5-fold 
dilutions of cells grown on plates supplemented with galactose to induce Rnq1 expression from 
the GAL1 promoter. (b) Localization of Rnq1-GFP-NLS and Rnq1-GFP via fluorescence 
microscopy in [RNQ+] and [rnq-] cells. 
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Figure 3.6 Rnq1-GFP-NLS assembles into SDS-resistant [RNQ+] prions with greater 
efficiency. (a) SDD-AGE analysis of the time course for the assembly of SDS-resistant [RNQ+] 
prions after induction of Rnq1 expression with galactose. (b) Filter trap analysis of Rnq1-GFP 
conversion to an SDS-resistant species at the indicated time after induced expression. Rnq1-GFP 
retained on the cellulose acetate filter was detected with α-GFP. (c) Time course of Rnq1-GFP 
expression determined by western blot. (d) Populations of Rnq1-GFP species as determined by 
size exclusion chromatography 4 hrs after induction of Rnq1 expression. Input corresponds to 
10% of the total Rnq1-GFP protein loaded.  
  
88 
 
45% behaved as a lower molecular weight unassembled species. The nuclear 
environment appeared to enhance the efficiency of Rnq1 assembly into [RNQ+] prions 
because 85% of total Rnq1-GFP-NLS behaved as a high molecular weight species and 
little unassembled Rnq1-GFP-NLS was detected (Figure 3.6d). Thus, changing the 
cellular location of Rnq1 from the cytosol to the nucleus does not affect expression levels 
of Rnq1, but does decrease the pool of unassembled Rnq1 whose accumulation is 
associated with cell death (Douglas et al., 2008).  
The dramatic decrease in unassembled Rnq1 pools observed does not appear to be 
related to degradation of Rnq1 because levels of total Rnq1-GFP and Rnq1-GFP-NLS are 
similar (Figure 3.6c). Instead, the decrease in unassembled Rnq1 observed when it 
accumulates in the nucleus correlates with a 1.5 fold increase in the accumulation of 
SDS-resistant Rnq1 aggregates (Figure 3.6a and b), which exhibit several features of 
amyloid (Douglas et al., 2008). These data suggest that conversion of Rnq1 into amyloid-
like [RNQ+] prions is more efficient in the nucleus. This environment-dependent increase 
in [RNQ+] prion formation appears cytoprotective because it prevents the accumulation 
of unassembled Rnq1 pools that are associated with cell death. 
 
Nuclear [RNQ+] prions act in trans to detoxify Rnq1 L94A 
Nuclear [RNQ+] prions appear to prevent the accumulation of toxic Rnq1 
conformers in the cytosol by acting as seeds that drive the ordered assembly of amyloid-
like aggregates in the nucleus. If this is true then the location of pre-existing [RNQ+] 
prion pools should dictate the site where soluble Rnq1 is converted into its [RNQ+] prion 
form. To test this prediction, we asked if an NLS-tagged pool of [RNQ+] prions could act 
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in trans to concentrate nascent Rnq1 in the nucleus and thereby suppress Rnq1 toxicity 
(Figure 3.7). Rnq1-GFP-NLS or Rnq1-GFP under control of the CUP1 promoter was first 
expressed at low non-toxic levels, which allowed for the formation of either nuclear or 
cytosolic [RNQ+] prions, respectively (Figure 3.7a). After a time period that allowed for 
distinct compartmentalization of the GFP-tagged [RNQ+] prions, expression of Rnq1-
mRFP under control of GAL1 promoter was induced for 1 hr and fluorescence of the 
different tagged proteins was visualized. We found that the subcellular location of Rnq1-
mRFP was dependent upon the localization of preformed GFP-tagged [RNQ+] prions 
(Figure 3.7a). Nearly the entire pool of newly synthesized Rnq1-mRFP became co-
localized with pools of nuclear [RNQ+] prions that accumulated during the prior 
expression of Rnq1-GFP-NLS (Figure 3.7a). Importantly, the severe growth defects 
caused by GAL1 dependent Rnq1-GFP L94A overexpression were suppressed through 
prior low-level expression of Rnq1-GFP-NLS (Figure 3.7b). Therefore, [RNQ+] prions 
can act in trans to both alter the subcellular location and toxicity of Rnq1.   
To further demonstrate the concept that pools of amyloid-like assemblies can trap 
native amyloidogenic proteins in a specific location, we conducted cytoduction 
experiments (Figure 3.7c). Cytoduction refers to an experimental situation where haploid 
yeast initiate the mating process, fuse their plasma membranes, and mix cytosolic 
contents, but fail to undergo karyogamy because one of the tester stains is defective in 
nuclear fusion (Conde and Fink, 1976). This scenario allowed us to monitor the fate of 
soluble Rnq1-mRFP in the cytosol of [rnq-] cells that was introduced into [RNQ+] cells, 
which harbored pre-existing nuclear [RNQ+] prions formed by Rnq1-GFP-NLS (Figure 
3.7c). GFP-tagged [RNQ+] prions present in the nucleus of [RNQ+] cells depleted the 
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Figure 3.7 Expression of Rnq1-GFP-NLS suppresses Rnq1 L94A toxicity and promotes the 
nuclear accumulation of Rnq1-mRFP. (a) Prior expression of Rnq1-GFP-NLS leads to the 
accumulation of Rnq1-mRFP in the nucleus. Rnq1-GFP or Rnq1-GFP-NLS were expressed 
overnight at low, non-toxic levels from the CUP1 promoter. Subsequent expression of Rnq1-
mRFP from the GAL1 promoter was induced by the addition of galactose. After 1hr, the location 
of the GFP and mRFP signals was determined in fixed, DAPI-stained cells by fluorescence 
microscopy. (b) Analysis of cell growth in 5 fold serial dilutions of [RNQ+] cells which harbored 
the indicated constructs. Cells were grown overnight in synthetic media to allow for Rnq1-GFP or 
Rnq1-GFP-NLS expression. Cells were then plated on agar that contained glucose (the control) or 
galactose to induce Rnq1-GFP L94A expression to toxic levels. (c) Rnq1-GFP-NLS in the 
nucleus of cytoduced [RNQ+] cells sequesters Rnq1-mRFP from the cytoplasm of [rnq-] cells. 
Cell fusion was analyzed 30 mins (Top row, control) and 2 hrs (bottom) after cell mixture. Merge 
images represent the combination of all fluorescent channels.  
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cytosol of [rnq-] cells of soluble Rnq1-mRFP and drove the assembly of a hybrid 
aggregate that contained both GFP and mRFP. Thus, nuclear [RNQ+] prions do indeed 
trap soluble Rnq1 in the nucleus by driving their fusion into large assemblies whose size 
constraints prevent export back to the cytosol. In this situation, the nuclear envelope acts 
as a sieve that helps suppress Rnq1 toxicity by sequestering prions in the nucleus, which, 
in turn, enhances [RNQ+] prion assembly. 
 
Nuclear [RNQ+] prions concentrate Htt-103Q in the nucleus and exacerbate Htt 
toxicity 
[RNQ+] prions promote Htt-103Q toxicity in yeast (Meriin et al., 2002) and 
movement of polyQ-expanded Htt protein from the cytosol to the nucleus of neurons and 
yeast correlates with exacerbated toxicity (DiFiglia et al., 1997; Schaffar et al., 2004). 
Yet, it is not clear how interaction with [RNQ+] prions or entry into the nuclear 
environment fosters toxicity of polyQ-expanded fragments of Htt exon-1 (Dunah et al., 
2002; Schaffar et al., 2004). To address these issues, we investigated the effects that Sis1 
overexpression had on the ability of the cell to tolerate Htt-103Q expression (Figure 3.8). 
While Sis1 expression suppressed Rnq1 toxicity (Fig. 1), the growth of yeast expressing 
Htt-103Q was slowed dramatically by Sis1 overexpression (Figure 3.8a). Interestingly, 
Sis1 overexpression also resulted in the nuclear accumulation of Htt-103Q-GFP 
aggregates in 15% of cells analyzed by fluorescent microscopy (Figure 3.8b). Based on 
these data, we explored whether [RNQ+] prions could act as environmental factors that 
increase Htt toxicity via attracting Htt-103Q to the nucleus (Figure 3.9 and 3.10).   
 To address this question we examined the effect that expression of low, non-toxic 
levels of Rnq1-GFP or Rnq1-GFP-NLS had on Htt-103Q toxicity. These Rnq1 variants  
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Figure 3.8 Elevation of Sis1 levels exacerbate growth defects caused by Htt-103Q 
overexpression.  (a) Growth of [RNQ+] yeast that harbored Sis1 and/or Htt-103Q overexpression 
constructs as indicated. (b) Cellular localization of Htt-103Q-GFP in [RNQ+] cells with and 
without Sis1 overexpression as determined by fluorescence microscopy. DNA is stained with 
DAPI. 
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were expressed, then expression of Htt-103Q was induced and the influence of [RNQ+] 
prion cellular location on Htt toxicity was evaluated. Growth of yeast was not impacted 
upon expression of Htt-25Q regardless of whether [RNQ+] prions were predominantly 
localized in the cytosol or nucleus (Figure 3.9a).  Yet, in dramatic contrast to what was 
observed with Rnq1 toxicity, the presence of small pools of [RNQ+] prions in the nucleus 
exacerbated Htt-103Q toxicity. The effect of Rnq1 localization on Htt toxicity was 
dependent upon the presence of the [RNQ+] prion conformer because Htt-103Q 
expression was not toxic in [rnq-] cells regardless of whether Rnq1-GFP or Rnq1-GFP-
NLS was present (Figure 3.10). 
To explain the increase in Htt toxicity observed in the presence of nuclear [RNQ+] 
prions, we asked if the cellular location of [RNQ+] prions controlled the location of Htt-
103Q (Figure 3.9b). Rnq1-mRFP or Rnq1-mRFP-NLS were expressed at low levels from 
the CUP1 promoter to permit the formation of respective cytosolic and nuclear pools of 
mRFP-tagged [RNQ+] prions. Then, expression of Htt-25Q-GFP or Htt-103Q-GFP from 
the GAL1 promoter was induced for 1 hr and cells were visualized. The site of Rnq1 
localization had no effect on the solubility or distribution of Htt-25Q-GFP (Figure 3.9b 
left columns). Conversely, the location of [RNQ+] prions controlled the subcellular 
location of Htt-103Q-GFP (Figure 3.9b right columns).  Nuclear [RNQ+] prions relocated 
Htt-103Q-GFP to the nucleus through what appeared to be direct interactions as their 
localization was coincidental. The association between [RNQ+] prions and Htt-103Q was 
dependent upon the length of the expanded polyQ-region. In addition, interaction 
between [RNQ+] prions and Htt-103Q appeared specific, because [RNQ+] prions did not  
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Figure 3.9 The presence of [RNQ+] prions in the nucleus exacerbates Htt-103Q toxicity. (a) 
Analysis of cell growth in 5-fold serial dilutions of [RNQ+] cells, which harbored the indicated 
constructs. Rnq1-GFP and Rnq1-GFP-NLS were first expressed at non-toxic levels from a CUP1 
promoter in liquid media containing copper. Then, Htt-25Q-GFP and Htt-103Q-GFP were 
expressed at toxic levels from the GAL1 promoter on galactose plates. (b) The impact of Rnq1-
mRFP-NLS expression on the cellular localization of Htt-25Q-GFP and Htt-103Q-GFP.  
 
 
95 
 
 
 
Figure 3.10 Rnq1-GFP-NLS exacerbates Htt-103Q toxicity in [RNQ+] cells but has no affect 
on Htt-103Q toxicity in [rnq-] cells.  Analysis of cell growth in 5 fold serial dilutions of [RNQ+] 
and [rnq-] cells, which harbored the indicated constructs.  Rnq1-GFP and Rnq1-GFP-NLS were 
first expressed at low non-toxic levels from a CUP1 promoter in liquid media containing copper.  
Then, Htt-103Q-GFP was expressed to toxic levels from the GAL1 promoter on galactose plates. 
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alter the location of another amyloid-like interaction partner, Het-S, that lacks polyQ 
expansions (Figure 3.11) (Taneja et al., 2007).  
To demonstrate a physical interaction between [RNQ+] prions and Htt-103Q, we 
analyzed whether they could form an immunoprecipitable complex. First, endogenous 
Rnq1 was demonstrated to co-precipitate with Htt-103Q-GFP (Figure 3.12a). SDS-
soluble forms of Htt-103Q-GFP protein that are capable of migrating into the SDS-PAGE 
gels showed no substantial co-precipitation with Rnq1. Yet, the SDS-insoluble Htt-103Q 
aggregates, which were incapable of entry into the SDS-PAGE gel, precipitated with 
Rnq1 and could be observed as immuno-reactive bands at the top of western blots. In 
addition, overexpressed Rnq1-GFP and Rnq1-GFP-NLS could also co-immunoprecipitate 
with SDS-resistant Htt-103Q aggregates (Figure 3.12b). Hence, nuclear [RNQ+] prions 
appear to trap Htt-103Q in the nucleus through direct binding to Htt-103Q. 
To explore the mechanism for exacerbation of Htt-103Q toxicity, we investigated 
how nuclear [RNQ+] prions affected the assembly status of Htt-103Q (Figure 3.13).  
Accumulation of [RNQ+] prions in the cytosol had no significant effect on the assembly 
of Htt-103Q into an SDS-resistant species that was detected by filter-trap analysis. In 
addition, Htt-103Q expression had no effect on the assembly of Rnq1 into [RNQ+] prions 
(data not shown). Yet, when nuclear [RNQ+] prions were present, the conversion of Htt-
103Q into tight SDS-resistant aggregates was reduced by 80% (Figure 3.13a).  
The accumulation of a small oligomeric form of polyQ-expanded Htt in the size 
range of a dimer or trimer is linked to Htt toxicity in yeast (Behrends et al., 2006). Thus, 
we asked if decreased formation of SDS-resistant, Htt-103Q assemblies observed in the 
presence of nuclear [RNQ+] prions was associated with the accumulation of similar 
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Figure 3.11 Expression of Rnq1-mRFP-NLS was unable to sequester the non-Q-rich Het-S 
prion to the nucleus. Rnq1-mRFP and Rnq1-mRFP-NLS were first expressed at low, non-toxic 
levels from a CUP1 promoter in liquid media containing copper.  Then, Het-S-GFP was 
expressed from the GAL1 promoter by addition of galactose to the media. The localization of 
Het-S-GFP was monitored in the absence of exogenous Rnq1 (left column) or in the presence of 
exogenous Rnq1-mRFP (middle column) or Rnq1-mRFP-NLS (right column) by fluorescence 
microscopy.  
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Figure 3.12 [RNQ+] prions form an immunoprecipitable complex with high molecular 
weight Htt-103Q. (a) Co-precipitation of endogenous Rnq1 and Htt-103Q in complex with each 
other. Extracts were generated from cells expressing Htt-103Q and endogenous Rnq1 was 
precipitated under native conditions with α-Rnq1. Precipitates were resolved by SDS-PAGE and 
western blots were probed with α-GFP to detect Htt-103Q. (b) Co-precipitation of Rnq1-GFP or 
Rnq1-GFP-NLS and Htt-103Q in complex with each other. Extracts were prepared from cells 
grown in liquid culture that sequentially expressed Rnq1 and Htt fusion proteins as described 
above. Rnq1-GFP and Rnq1-GFP-NLS were precipitated under native conditions by the addition 
α-Rnq1 and western blots were probed with α-GFP to detect the different forms of Rnq1 and Htt. 
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detergent-soluble Htt-103Q oligomers (Figure 3.13b). Under control conditions, 70% of 
Htt-103Q in cell extracts migrated on a size exclusion column as a high-molecular weight 
species that was SDS-resistant and could not enter into SDS-PAGE gels. The other 30% 
of Htt-103Q detected behaved as an SDS-sensitive form that could enter into SDS-PAGE 
gels and appeared as a small oligomer. Yet, the presence of nuclear [RNQ+] prions 
dramatically reduced the formation of high-molecular weight, Htt-103Q assemblies. This 
was accompanied by a corresponding increase in the accumulation of SDS-sensitive, 
oligomeric Htt-103Q. Therefore, increased potency of Htt toxicity observed in the 
presence of nuclear [RNQ+] prions is associated with a dramatic decrease in the 
conversion of Htt-103Q into an SDS-resistant species and the accumulation of small Htt-
103Q oligomers. 
We sought to evaluate whether interaction with [RNQ+] prions or the relocation of 
Htt-103Q to the nucleus was the major factor that decreased the cells capacity to detoxify 
Htt-103Q. To approach this question, an NLS was fused to the C-terminus of the GFP 
moiety on Htt-103Q-GFP and the ability of Htt-103Q-GFP-NLS to form SDS-resistant 
aggregates and kill yeast was determined (Figure 3.14). Htt-103Q-GFP-NLS accumulated 
in the nucleus and was more toxic to [RNQ+] cells than Htt-103Q-GFP.  Yet, [rnq-] cells 
tolerated Htt-103Q-GFP-NLS expression (Figure 3.14a and b).  When compared to Htt-
103Q-GFP, the assembly of Htt-103Q-GFP-NLS into high-molecular weight, SDS-
resistant aggregates was reduced by over 60% (Figure 3.14c).  This decrease in the 
formation of SDS-resistant aggregates was accompanied by a significant increase in the 
amount of detergent-soluble, Htt-103Q oligomers that were detected by size-exclusion 
chromatography (Figure 3.14d). These data suggest that the ability of nuclear [RNQ+] 
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Figure 3.13 Nuclear [RNQ+] prions hinder the assembly of Htt-103Q into high molecular 
weight, SDS-resistant aggregates. (a) Filter trap analysis of SDS-resistant Htt-103Q aggregates. 
Htt-103Q retained on the cellulose acetate filter was detected with α-FLAG. Lower panels are 
western blots of cell extracts used in the filter trap assay. (b) Analysis of Htt-103Q assembly 
status by size exclusion chromatography. Htt-103Q was expressed for 2 hrs in cells that harbored 
Rnq1-GFP or Rnq1-GFP-NLS. Upper gels in each set of panels show the quantity of SDS-
resistant Htt-103Q that was incapable of gel entry. Middle gels in each set of panels show the Htt-
103Q which was able to migrate into gels. Lower gels in each set of panels show the mobility of 
either Rnq1-GFP or Rnq1-GFP-NLS. Input represents 10% of the total amount of Htt-103Q-GFP 
protein detected in extracts.  
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Figure 3.14 Htt-103Q-GFP-NLS forms SDS-resistant aggregates with reduced efficiency 
and is dramatically more toxic than Htt-103Q-GFP. (a) Analysis of cell growth in 5 fold serial 
dilutions of [RNQ+] and [rnq-] cells harboring the indicated forms of Htt-103Q that were 
expressed from the GAL1 promoter. (b) Cellular localization of Htt-103Q-GFP and Htt-103Q-
GFP-NLS in [RNQ+] and [rnq-] cells as determined by fluorescence microscopy. (c) Filter trap 
analysis of SDS-resistant Htt-103Q and Htt-103Q-GFP-NLS aggregates. Lower panels are 
western blots of cell extracts used in the filter trap assay. (d) Comparison of Htt-103Q-GFP and 
Htt-103Q-GFP-NLS assembly status in [RNQ+] cells by size exclusion chromatography. Htt-
103Q chimeras were expressed for 2 hrs in cells harboring only endogenous Rnq1.  
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prions to exacerbate Htt-103Q toxicity can be accounted for via their attracting Htt-103Q 
to an environment that has reduced capacity to convert it into an SDS-resistant species. 
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3.4 Discussion  
Herein we demonstrate that yeast partition the model disease proteins, Rnq1 and 
Htt-103Q, between benign and toxic states with reciprocal efficiencies in the cytosol and 
nucleus.  The nuclear environment favors assembly of Rnq1 into benign, amyloid-like 
[RNQ+] prions. Yet, Htt-103Q assembly into SDS-resistant particles is disfavored in the 
nucleus. An important component of the cells defense against Rnq1 and Htt-103Q 
toxicity is their efficient conversion to an SDS-resistant species. Yet, the cytosol and 
nucleus possess unique capacities to package different disease proteins into benign 
assemblies. These data help explain why relocation of disease proteins from the cytosol 
to the nucleus (Davies et al., 1997; Ross, 1997; Saudou et al., 1998) or the nucleus to the 
cytosol exacerbates toxicity (Neumann et al., 2006).  
Data presented suggest several mechanisms by which changes in a disease 
protein’s neighbors influence its localization and toxicity. The assembly of disease 
proteins into tightly aggregated species can represent a protective mechanism, but, 
surprisingly, is not a spontaneous process (Behrends et al., 2006; Cohen et al., 2006; 
Douglas et al., 2008). Different classes of molecular chaperones, whose expression is 
controlled in an age and stress dependent manner, prevent the accumulation of toxic 
detergent-soluble oligomers by facilitating conversion of disease proteins into different 
types of aggregated species (Behrends et al., 2006; Douglas et al., 2008). Increased 
activity of the Hsp40, Sis1, within physiological ranges, shifted the localization of the 
[RNQ+] prion assembly pathway from the cytosol to the nucleus. This relocation 
appeared to result from the retention of native Rnq1 in nuclear [RNQ+] prions, which is 
accomplished by increased prion assembly in this location and the inability of prions to 
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traffic out of the nucleus. Thus, the differential ability of chaperones to function in 
assembly events in the cytosol and nucleus can influence the intracellular location and 
toxicity of disease proteins.  
Modest changes in chaperone activity can also influence the localization and 
conformation of disease protein interaction partners. This can have dramatic downstream 
effects on the disease protein’s localization and environment. This, in turn, has profound 
positive or negative effects on the cell’s ability to detoxify disease proteins. PolyQ 
proteins expose promiscuous interaction surfaces that are capable of interactions with 
other polyQ proteins (Duennwald et al., 2006), which can impact polyQ protein 
localization (Perez et al., 1998). We report that relocation of [RNQ+] prions from the 
cytosol to the nucleus also leads to the accumulation of Htt-103Q in the nuclear 
environment where it is more toxic. Thus, changes in the conformation and/or location of 
human polyQ interacting proteins (Duennwald et al., 2006) has the potential to impact the 
location and detoxification of pathogenic polyQ proteins.     
Several factors may explain the apparent changes in the efficiency of [RNQ+] 
prion formation and Htt-103Q aggregate assembly observed when this process occurs in 
the nucleus instead of the cytosol. First, total Rnq1 levels are comparable when Rnq1 
accumulates in the cytosol or nucleus, yet the nucleus possesses a smaller volume than 
the cytosol. Accumulation in the nucleus may therefore increase the local Rnq1 
concentration and enhance the efficiency of [RNQ+] formation by mass action. However, 
the same logic does not work when Htt-103Q assembly into SDS-resistant aggregates is 
considered. Thus, it is more likely that the cytosol and nucleus contain different levels of 
proteins that either promote or hinder Rnq1 and Htt-103Q detoxification. Hsp104 is a 
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cytosolic shearing factor, whose levels are low in the nucleus (Tkach and Glover, 2008), 
which acts in conjunction with Sis1 to fragment [RNQ+] prions into smaller seeds (Aron 
et al., 2007; Tipton et al., 2008) that are required to promote prion propagation (Chernoff 
et al., 1995) as well as to nucleate formation of toxic Rnq1 species (Douglas et al., 2008). 
In contrast, TriC is a ringed chaperonin required for polyQ detoxification (Behrends et 
al., 2006; Kitamura et al., 2006; Tam et al., 2006) that is localized primarily in the cytosol 
(Kim et al., 1994). Thus, [RNQ+] prion assembly may benefit from the nuclear 
environment because Hsp104 is less active in this compartment. Yet, the absence of TriC 
in the nucleus could explain the enhanced toxicity and reduced aggregation efficiency of 
nuclear Htt-103Q. 
The majority of Sis1 is normally found in the nucleus (Luke et al., 1991), which 
helps explain why subtle elevations in Sis1 levels increase [RNQ+] prion formation in this 
compartment. We surmise that pools of Rnq1 normally traffic between the cytosol and 
nucleus and increasing nuclear Sis1 levels helps drive the fusion of Rnq1 monomers into 
nuclear [RNQ+] prion seeds. However, Type II Hsp40s are known to help retain proteins 
in the nucleus (Cheng et al., 2008; Zhang et al., 2008), so it also possible that Sis1 has a 
direct impact on the nucleocytoplasmic trafficking of Rnq1. Indeed, the non-prion 
domain of Rnq1 contains a hydrophobic Sis1 binding site that closely resembles a 
canonical nuclear export signal (Douglas et al., 2008). Sis1 binding to Rnq1 may 
therefore negatively regulate Rnq1 nuclear export and thereby increase nuclear Rnq1 
levels. However, it was difficult to test this hypothesis because mutation of the putative 
NES within Rnq1 hindered Sis1 binding and altered the aggregation state of Rnq1 (data 
not shown). Nevertheless, it is clear that Hsp40s can directly and indirectly modulate the 
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cellular location where disease proteins are assembled into aggregates. This action can 
have protective or toxic consequences. 
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3.5 Materials and methods 
Strains and Plasmids: Yeast strains W303, YEF473B, BY4742, and 10B-H49 were 
utilized to take advantage of different genetic markers, gene integrations, gene deletions 
and karyogomy defects. W303, MATa and α, can1-100 ade2-1, his3-11,15 leu2-3,112 
ura3-1 trp1-1; YEF473B, MATα, trp1Δ63, leu2Δ, ura3-52, his3Δ200, lys2-8Δ1, NUP49-
GFP::HygB; 10B-H49 MATα, ρ° ade2–1, lys1–1, his3–11,15, leu2–3,112, kar1–1, 
ura3::KANR; BY4742 MATα, his3Δ, leu2Δ, lys2Δ, ura2Δ. All strains harbored Rnq1 in 
its [RNQ+] form and the generation of isogenic [rnq-] strains was accomplished via 
sequential passage of cells on plates containing 3 mM guanidinium-HCl (Douglas et al., 
2008). Strains were transformed with plasmids and cultured in synthetic media as 
previously described (Douglas et al., 2008).  Individual gene deletions in the BY4742 
strain background were obtained from Open Biosystems. Plasmids that express the 
indicated protein under control of the GAL1 promoter include pRS416-RNQ1, pRS416-
RNQ1-GFP, pRS416-RNQ1-GFP L94A, pRS416-RNQ1-GFP-NLS, pRS416-RNQ1-
GFP-NLS L94A, pYES3-SIS1, pYES3-Flag-Htt-103Q-GFP, pYES3-Flag-Htt-25Q-GFP, 
pYES2-Flag-Htt-103Q-GFP, pYES2-Flag-Htt-25Q-GFP and pRS414-Het-S-GFP (Taneja 
et al., 2007). Plasmids that express Rnq1 under control of the CUP1 promoter include 
pRS316-RNQ1-GFP, pRS316-RNQ1-GFP-NLS, pRS315-RNQ1-GFP and pRS315-
RNQ1-GFP-NLS. The mRFP tag (Sato et al., 2005) was subcloned in place of the GFP 
(between SacI and SacII restriction enzyme cut sites) in all of the CUP1 inducible Rnq1 
constructs. The NLS sequence was derived from the HIV SV-40 and encodes the amino 
acid sequence PKKKRKV which was fused to the carboxy-terminus of the GFP or mRFP 
tag.  The NES sequence was derived from the yeast Ssb1 chaperone and encodes the 
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amino acid sequence KIEAALSDALAALQ which was fused to the C-terminus of GFP.  
The open reading frame of Sup35 was subcloned from genomic DNA between a 5’ 
BamHI and 3’ SacI restriction enzyme cut sites and subcloned into CUP1 inducible 
vector to generate pRS316-Sup35-GFP. The glyceraldehyde-3-phosphate dehydrogenase 
(GPD) promoter controlled expression of pRS315-SSA1, pRS315-HSP104, pRS315-SIS1, 
and pRS414-SIS1. The QuikChange site-directed mutagenesis kit (Stratagene) was used 
to create the indicated point mutations in Rnq1. pKW430 expressed a nucleocytoplasmic 
reporter composed of the following moieties, NLSSV40-NESPKI-2 x GFP (Stade et al., 
1997).  
 
Sytox dye exclusion: W303α cells were sequentially transformed with pRS414-SIS1 or 
pRS414 and then pRS416-RNQ1 or pRS416. Transformants were grown overnight to an 
OD600 of 0.2-0.4 in synthetic media containing raffinose as the carbon source. Galactose 
(2%) was added to the media to induce Rnq1 expression from the GAL1 promoter in 
pRS416-RNQ1. Cells were collected and sytox permeability was measured with a 
FluoSTAR fluorometer (Zakrzewska et al., 2007). 
 
Fluorescence Microscopy:  Rnq1-GFP or Rnq1-mRFP as well as Htt-25Q-GFP and Htt-
103Q-GFP were expressed under control of the indicated inducible promoters. Images 
were captured from live or fixed cells in synthetic liquid media with a Nikon E600 
fluorescence microscope and images were processed with Metamorph and Adobe 
Photoshop Software. The nuclear envelope was delineated via visualization of the nuclear 
pore protein, Nup49-GFP. 
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In the order of expression experiments, cells harbored two distinct plasmids which 
expressed two proteins from either the GAL1 or CUP1 promoters. Cells were grown 
overnight at 30°C in synthetic media containing raffinose (2%) to OD600 of 0.5-1.5. 
Enough Cu++ was present in the media to allow for the visualization of the indicated 
Rnq1-GFP and Rnq1-mRFP protein from the CUP1 promoter.  The media was then 
supplemented with galactose (2%) to induce expression of the indicated protein under 
control of the GAL1 promoter. Following a 1-2 hr incubation, cells were collected and 
photographed live or fixed. 
Cells were stained with DAPI to visualize nuclear DNA. Cells were first fixed 
with 4% formaldehyde for 30 min, washed twice with PBS and permeabilized by 
incubation in 0.5% PBS Triton for 10 min. Cells were then washed twice with PBS, 
incubated for 10 min with DAPI (1 μg/ml), and again washed twice with PBS before 
visualization.   
 
Cytoduction: W303a [RNQ+] cells that harbored pRS416-GAL1-Rnq1-GFP-NLS were 
grown overnight in synthetic dropout media containing raffinose (2%). Once cells 
reached an OD600 of 0.5-1.5, media was supplemented with galactose (2%) and incubated 
for 1-2 hr. Cells were then mated with a [rnq-] strain that is defective in karyogamy,10B-
H49α (Sondheimer and Lindquist, 2000). Prior to mating, 10B-H49α [rnq-] cells 
harboring pRS315-CUP-Rnq1-mRFP, were cultured overnight at 30°C in synthetic 
media. Cells with an OD600 of 0.5-1.5 were supplemented with CuSO4 (50 μM) and 
cultured for an additional 2-3 hrs before mated. Mating was conducted with 2 OD600 units 
of cells from either mating type that were washed with sterile ddH2O, mixed and 
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incubated on YPD plates. Incubations were performed at 30°C for either 30 mins or 2 hrs 
after which cells were scraped and washed with sterile PBS. Mated cells were fixed in 
formaldehyde and stained with DAPI before visualization. 
 
Analysis of Rnq1 and Htt-103Q toxicity: Cell growth on agarose plates was monitored 
in [RNQ+] and [rnq-] W303α strains that harbored pRS416-RNQ1-GFP, pRS416-RNQ1-
GFP-NLS, pYES2-Flag-Htt-103Q-GFP or pYES2-Flag-Htt-103Q-GFP-NLS under 
control of the GAL1 promoter. In the order of expression experiments, cells were 
transformed with two plasmids that expressed the indicated proteins under control of the 
GAL1 or CUP1 promoter. Cells were grown overnight in synthetic media containing 
raffinose (2%) to an OD600 of 1-2 before 5-fold dilutions were spotted onto plates 
containing galactose (2%). Enough Cu++ was present in the synthetic media to allow for 
modest, non-toxic overexpression of the indicated Rnq1 proteins off the CUP1 promoter. 
Plates were incubated for 3-5 days at 30ºC before being photographed. 
 Cell growth in liquid culture was monitored in [RNQ+] W303α strains that 
harbored pRS315-GPD or pRS315-GPD-SIS1 and pYES2 or pYES2-Flag-Htt-103Q-
GFP under control of the GAL1 promoter. Cell cultures in synthetic media containing 
2% raffinose were grown to an O.D. of 4-6 overnight. Cultures were then diluted to an 
O.D of 0.01 and allowed to grow for 4hrs before the addition of 2% galactose to induce 
expression of Htt-103Q. Cell concentration was determined at the indicated time points 
by light scattering at 600 nM. 
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Screen of yeast strains for nuclear trafficking factors required for suppression of 
Rnq1 toxicity. BY4742 strains from the yeast deletion collection that harbored the 
indicated deletions of non-essential genes were sequentially transformed with pRS315-
GPD-SIS1 and then pRS316-CUP1-RNQ1-GFP. Transformants were cultured in 
synthetic media overnight at 30°C to an OD600 of 0.5-2. Enough Cu++ was present in the 
media to allow for Rnq1-GFP expression and visualization. Rnq1-GFP was either 
distributed throughout the whole cell and scored as cytoplasmic or compartmentalized to 
the nucleus. The localization of Rnq1-GFP in different deletions strains was analyzed in 
200 cells from 3-5 separate transformations.   
 
Analysis of SDS-resistant Htt-103Q and Rnq1 aggregates: Monitoring the assembly of 
Rnq1 and Htt-103Q into SDS-resistant aggregates was performed as previously described 
by SDD-AGE (Douglas et al., 2008; Kryndushkin et al., 2003). For filter trap analysis, 
cell extracts were generate in non-denaturing lysis buffer previously described (Douglas 
et al., 2008). The lysate was added to a 2X slot blot sample buffer which contained a final 
concentration of 2% SDS, 75 mM Tris-HCl pH 6.8, 2 mM EDTA, 8% 2-
mercaptoethanol, 2 mM phenylmethysulfonyl fluoride and a protease inhibitor cocktail 
(Roche).  40μl of the final sample was added to the wells of the slot blot apparatus which 
contained an equilibrated cellulose acetate membrane filter (Scherzinger et al., 1997).  
Equilibration of cellulose acetate was achieved by adding 100 μl of 1X slot blot buffer to 
the wells.  The vacuum was never applied to the slot blot apparatus.  Once samples ran 
through the filter and wells appeared dry, 100 μl of 0.1% SDS was added to the wells. 
Once dry, the membranes were washed 3 times in PBS, blocked overnight in 10% milk at 
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4°C and western blotted as previously described (Douglas et al., 2008). PVDF or 
cellulose acetate membranes were probed with α-GFP to visualize Rnq1-GFP and α-Flag 
to visualize Flag-Htt-103Q-GFP. Monitoring protein levels by western blot was 
performed as previously described (Douglas et al., 2008). 
 
Rnq1 co-immunoprecipitation with Htt: Expression of Htt-103Q-GFP in cells 
harboring pYES3-Htt-103Q-GFP was induced by supplementation with 2% galactose. 
Non-denaturing cell extracts were generated 2 hrs later under the conditions described 
(Fan et al., 2004), and α-Rnq1 was added to lysates. Htt-103Q-GFP was 
immunoprecipitated with endogenous Rnq1 and detected with α-GFP by western blot. 
Similarly, Rnq1-GFP and Rnq1-GFP-NLS were immunoprecipitated with α-Rnq1 and 
probed for binding with Htt-25Q-GFP or Htt-103Q-GFP.     
  
Size Exclusion Chromotagraphy: Non-denaturing cell extracts were generated under 
the conditions described (Behrends et al., 2006) and resolved on a Sephacryl S-200 Hi-
Prep column.  Samples were loaded onto the column and collected as previously 
described (Douglas et al., 2008).  
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